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SUM M ARY
Stress-induced antinociception (SIA) which is well characterised in the adult rat, 
can also be observed in young rats and by varying swimming times can be dissociated 
into opioid and non-opioid forms. However, swimming ability in the rat does not fu lly  
develop until the third postnatal week and this has precluded the study of swim SIA in 
neonates. In this study an attempt was made to develop a harness device to aid 
swimming in young rats. This device was employed successfully for the study of 
swim-SIA down to the age o f 2 days without distress to the animals. Ontogenetic 
study o f the opioid form of swim-SIA in the neonate rats using this device indicated 
that swim-SIA was absent at day 2 and day 5 but at postnatal day 10 a small level o f 
SIA was evident which was reversed by naloxone (lOmg/kg). Swim-SIA develops 
rapidly thereafter and the adult profile observed by day 25.
The effect of maternal diazepam exposure influencing the development o f opioid 
system functions, particularly stress-induced antinociception, in the neonatal offspring 
ha s been studied. Diazepam ( 1 or 10 mg/kg) was administered daily to mothers from 
conception to the postnatal day of experiment when the neonates were tested for swim- 
SIA. No significant effect o f diazepam treatment upon maternal or litte r weight gain 
was observed in all the groups over a chronic treatment period. Pre- and postweanling 
rat pups were assessed for opioid mediated stress-induced antinociception by 3min. 
swimming stress and measuring nociception using the tail immersion test. In 
preweanling rats stress-induced antinociception was observed in both vehicle and 
diazepam treated animals, but in diazepam treated groups (1 and 10 mg/kg) this was 
insensitive to reversal by the opioid antagonist naloxone suggesting that non-opioid 
systems are operating this response. In postweanling rats a sim ilar insensitivity to 
naloxone was observed in 1 mg/kg diazepam treated groups and w ith lOmg/kg 
diazepam there was no significant antinociception. The results suggest that maternal
diazepam treatment interferes with the development of stress-mediated responses and 
that part o f this toxicity is due to actions on opioid systems in the CNS.
The opioid type of swim-stress induced antinociception is mediated via /4-sites 
in preweanling rats and predominantly by ô-sites in postweanling animals. In this study 
the effect o f delay o f weaning on the receptor transition o f this behaviour in the 
developing rat has been investigated. Litters were weaned normally at day 21 or 
allowed to remain with their mothers until assessment of swim-SIA. Animals were 
stressed by warm water (20°C) swimming for 3min periods and antinociception 
assessed by the tail immersion test (50°C). Naloxone (lOmg/kg) partially reversed 
swim-SIA in both 25 day old weaned and non-weaned rats. Naltrindole (1 mg/kg) 
partially reversed swim-SIA in 25 day old weaned rats but had no effect in non-weaned 
animals. Naltrindole (5mg/kg) completely abolished swim-SIA in weaned rats but was 
without effect in non-weaned groups. Antinociceptive responses to the /4-agonist 
alfentanil (60mg/kg) were unaffected by naltrindole at 1 mg/kg but were partially 
reversed at 5mg/kg. In 30 day old non-weaned rats naltrindole (5mg/kg) abolished the 
swim-SIA. These findings indicate that transition from /4- to ô-receptor control o f 
swim-SIA in rat pups can be delayed by between 5 to 10 days by delay o f weaning and 
the environmental stimulus of weaning can activate opioid receptor subtype operation of 
biological responses in the developing animal.
The stimulus of weaning appeared to be the critical element necessary fo r the 
transition from / 4- to ô- receptor control o f swim-SIA in rat pups. To study whether 
weaning stimulates the development o f a subtype of the ô-opioid receptor, the 
antinociceptive activity o f putative agonists fo r Ôi^  (DELT I) and for Ô2 , (DSLET) 
receptors in weaned and non-weaned 25 day old rats was investigated. In  weaned rats, 
DSLET produced antinociception which was reversed by the Ô2 -antagonist, naltriben, 
but in the non-weaned rats DSLET had no effect. In contrast to these findings, dose
related antinociceptive responses to DELT I were evident in both weaned and non- 
weaned rats. These responses were not antagonised by naltriben. The results indicate 
that the ô i- and Ô2- opioid receptor subtypes develop differentially and independently 
and suggests that weaning is the stimulus for the expression o f the Ô2-opioid receptor 
subtype.
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CHAPTER ONE
14
1 GENERAL INTRODUCTION
1.1 STRESS-INDUCED-ANTINOCICEPTION (SIAl
Response.vto noxious or threatening stimuli is one of the basic adaptive mechanisms o f 
animals and humans (Cannon, 1939). Emergency situations are usually met by a 
number o f autonomic adjustments of varying duration such as changes in  heart rate, 
muscle vasodilation, pupillary dilation, glucose and fat mobilisation, constriction o f 
capillary beds in the skin and altered respiration as well as by a complex, but integrated 
neuroendocrine responses involving pituitary-adrenal-cortical and sympatho-medullary 
activation (Selye, 1952). The increased physiological and psychological demands o f the 
body following such activation are met by the release o f adrenocorticotrophin (ACTH) 
from the anterior pituitary, glucocorticoids from the adrenal cortex, adrenaline from the 
adrenal medulla, and noradrenaline from sympathetic nerves. Pain inhibitory systems 
are often also activated by such stimuli, resulting in antinociception which additionally 
offers significant advantages for the survival o f the organisms in a life  threatening 
situation. A normal reaction to painful stimuli could otherwise be a serious 
disadvantage during acute adaptation to severe environmental demands. The term 
stress-induced antinociception (SIA) has been used to describe this phenomenon, 
where environmental circumstances of stress application or encounter play ^  the crucial 
role in the development of antinociceptive response.
The phenomenon o f SIA has been a very valuable tool for investigating the nature and 
mechanisms of pain inhibitory systems. A variety of SIA studies have produced results 
many o f which have pharmacological and clinical implications. For instance, studies 
have shown that streptozotocin-induced diabetic mice exhibited foot shock induced SIA 
that is significantly lower than in control mice and unaffected by naloxone antagonism 
(Kamei et al., 1992a). In contrast, the diabetic mice and not the control mice exhibited 
significant antinociception one minute after swim stress that was blocked by
15
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pretreatment w ith naltrindole and not w ith B-funaltrexamine, an irreversible and 
selective /(-opioid receptor antagonist. These findings suggest that diabetes results in 
the deficiency o f /(-opioid receptor functioning and a significant activation of an 
endogenous antinociceptive system, which is mediated mainly by the ô-opioid receptors 
(Kamei et al., 1992a). Further to this, it was observed that in diabetic mice, acutely 
administered naloxone induced a potent antinociceptive effect that was also blocked by 
pretreatment with naltrindole and not with B-funaltrexamine (Kamei et al., 1992b).
1.2 PAIN INHIBITORY SYSTEM
The p h y s io lo g y  o f  p a in  c o n t r o l  s y s te m s L is  com plex ( f i g  1 ) .  
The first concrete evidence for the existence of endogenous pain inhibitory systems
came from the reports of Reynolds, (1969) and Mayer et. al., (1971) where electrical
stimulation o f the medial brainstem of rat caused potent antinociception. Similar
observations were subsequently reported in cats (Liebeskind et al., 1973), monkey
(Goodman et al., 1976) and humans (Richardson et al., 1977). Mayer et al., (1971)
found that the specificity o f Stimulation Produced Antinociception (SPA) in blocking
responses to noxious stimuli was suggestive o f the relatively specific pain suppressing
effects o f opioids and suggested that SPA might share sites and/or mechanism o f action
with opioid drugs. Support for this view came from the observations that stimulation
o f the periaqueductal region which yields profound SPA is also exquisitely sensitive to
morphine (Jacquet et al., 1974). Furthermore, morphine and repeated brain stimulation
exhibit tolerance and cross tolerance (Mayer and Hayes, 1975) and the opioid
antagonist naloxone, was found to significantly reduce SPA in the rat (A kil et al.,
1976b). However, not all SPA was antagonised by naloxone (Pert and Walter, 1976;
Yaksh et. al., 1976), an observation which led to the realisation o f naloxone-sensitive
and insensitive SPA regions. The reported existence of stereospecific binding sites for
opioids in the central nervous system (Pert and Synder, 1973) which were shown to be
and
localised to neuronal synaptic regions (Pert &  Synder, 1973)yyto overlap anatomically 
w ith loci active in the neural processing o f pain (Pert et al., 1975), coupled w ith the
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detection from brain extracts o f substances that exhibit opioid like activity (Hughes, 
1975), led to a greater understanding of the pain control systems. These and other 
(morphine like) endogenous substances later identified and collectively referred to as 
endogenous opioid peptides have been extensively studied for their role in the control 
o f nociception and in SIA. The receptors upon which they act have also been 
identified. For reviews see section 1.4 and 1.5.
1.3 STRESSORS AND MECHANISMS OF SIA
Following the discovery of an endogenous pain control system and its role in SPA, the 
question o f what environmental circumstances might trigger the activation o f this 
system arose. The first sets o f observations showing that exposure to stressful events 
in rats increased pain threshold came from the works o f A k il et al., (1976a); Hayes et 
al., (1976) and Rosecrans and Chance, (1976). A k il et al., (1976a) found that the 
antinociceptive effect of prolonged footshock was partially attenuated by naloxone and 
although others (Hayes et al., 1976) failed to observe this effect, the naloxone 
reversibility o f footshock antinociception suggested a possible involvement o f the 
opioid system in this phenomenon. Reversibility of the antinociceptive response o f a 
stressor, especially that involving the opiate antagonist naloxone (fo r review see 
M artin i, 1967), has been used in most studies to infer opioid involvement in stress- 
induced antinociception. A k il et al., (1976a) found that the development o f footshock 
antinociception was accompanied by a parallel increase in brain opioid levels which in 
time returned to normal levels but produced rats which were tolerant to the 
antinociceptive effects of footshock. The trials o f other environmental manipulations 
that were regarded as stressors subsequently followed and among them, inescapable 
footshock (Madden et al., 1977), coldwater swims (Bodnar et al, 1977; 1978a), 
injections o f 2-deoxy-D-glucose (Bodnar et al., 1978b), food deprivation (Bodnar et 
al., 1978c), immobilization (Amir and Amit, 1978), insulin injections (Bodnar et al., 
1979), heat exposure (Kulkarni, 1980) and body pinch (Omstein and Am ir, 1981)
18
were shown to increase pain threshold. However, other classical stressors such as 
ether vapours and horizontal oscillation were unable to increase pain threshold 
suggesting that stress per se was not the critical factor in the development o f 
antinociception. For a review on the types of stress which induce antinociception see 
Bodnar, (1984).
The mechanisms underlying the antinociception from these stressors have proven 
complex and were poorly understood, perhaps because o f the discrepant findings 
arising from the use o f diverse stressors and parameters of stress application. The 
discrepancies in the results obtained by Hayes et al., (1976) and A k il et al., (1976a), 
were explained by Lewis et al., (1980a) who used a single, constant-intensity 
inescapable footshock stress and found that by varying only its temporal parameters as 
brief, continuous, (3 minutes) and prolonged, intermittent (30 minutes) footshock, two 
equipotent forms o f antinociception could be produced. The latter and not the former 
was antagonised by naloxone, exhibited tolerance upon repeated exposure and was 
cross tolerant with morphine. These findings revealed the activation o f an opioid and 
non-opioid antinociceptive system of footshock which was dependent at least in part, 
on temporal characteristics of the stressor. W ith the application of criteria such as 
naloxone antagonism, cross tolerance w ith morphine and tolerance to the 
antinociceptive effect of stressor upon repeated exposure, it has been confirmed that 
stress-induced antinociception can be mediated by opioid (Maier et a., 1980; Drugan et 
al., 1981) and non-opioid mechanisms (Lewis et al., 1980cÿl981a). Identification o f 
the neurohumoral and neural pathways involved in the mediation o f opioid and non­
opioid SIA followed a number of experimental manipulations. These include regional 
application of stress to animals (Watkins et al., 1982a) and a variety o f manipulations 
o f the hypothalamo-pituitary-adrenal system such as hypophysectomy (Lewis et al., 
1981b), adrenalectomy, adrenal demedullation, and adrenal medullary denervation 
(Lewis et al., 1982). Other manipulations involved lesions of the dorsolateral funiculus 
(DLF) o f the spinal cord (Watkins et al., 1982b) and o f the nucleus raphe magnus, 
NRM, (Cannon et al., 1983). These studies and others demonstrated that pain
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inhibition resulting from the activation o f opioid or non-opioid systenymay or may not 
involve a hormonal and neural component and four categories o f antinociceptive 
response: neural/opioid, hormonal/opioid, neural/non-opioid and hormonal/non-opioid 
have been suggested. For reviews see Watkins and Mayer, (^98:^ Terman et a l.,(l98^ j 
Bodnar, ([990).
1.3.1 Swim Stress-Induced-Antinociception
Antinociception from cold water swim stress has been extensively studied and has been 
reported by some (Christie et al., 1982; Cooper and Carmody, 1982; Christie and 
Chesher, 1983) to meet several criteria for opioid mediation. As in footshock induced 
antinociception, parametric variables when applied in swim-stress can also determine 
whether opioid or non-opioid systems w ill participate in the mediation o f 
antinociceptive response (Bodnar and Sikoszky, 1983; Terman et al., 1986). It  is 
generally accepted that antinociception from lower severity cold water swims (higher 
temperature or briefer duration) is opioid mediated whereas antinociception from more 
severe swims (lower temperature or longer duration is non-opioid mediated in nature 
(Terman et al., 1986). This view is however in contrast to the report o f Tierney et al., 
(1991), who found that short cold water swims activate non-opioid while long swims 
activate opioid antinociceptive systems in the mouse. In agreement w ith the general 
concept, animals swum for 3 min in hot water (32°C) were found to exhibit naloxone- 
sensitive antinociception that is attenuated in morphine tolerant animals (Christie et al., 
1982). This swim parameter was however reported to induce antinociception in mice 
that has both opioid and non-opioid components (Vaccarino et al., 1992). Sim ilarly, 
rats which undergo a 3.5min swim in 15°C water produced an opioid antinociception 
(Bodnar and Sikoszky, 1983), whereas rats exposed to a continuous cold water swim 
(CCWS) in a 2°C bath for 3.5min, induced antinociception which was not eliminated 
by naloxone suggesting the activation o f a non-opioid pain inhibitory system (Bodnar 
and Sikoszky, 1983). These findings therefore supporti the proposal that higher
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temperatures activate- opioid and lower temperatures activate;; non-opioid 
antinociceptive systems. Other parameters of swim stress have been employed by 
varying the number, duration and pattern of exposure, and have been shown to 
specifically activate different types o f cold water stress antinociceptive systems 
(Girardot and Holloway, 1984; 1985). Thus, rats exposed to intermittent cold water 
swim (ICWS) in a 2“C water, consisting a total o f 18 exposures, 3 exposures per min 
and o f a 10 sec duration each, have displayed antinociception involving an opioid- 
mediated system since the antinociception was attenuated by the opioid antagonist, 
naltrexone and was cross tolerant w ith morphine antinociception (Girardot and 
Holloway, 1 9 8 4 ;G ira ra o t& H o llo w a ^9 8 ^ M ic e  exposed to 3 min continuous 
swim in  warm water at 20-2 r c  has also been shown to result in a 25-30min o f 
antinociception which, at its peak, is more potent than that produced by 15mg/kg 
intraperitoneal morphine (Carmody and Cooper, 1987). This antinociception is 
believed to be wholly opioid in nature, being abolished by a moderate dose (Img/kg) of 
naloxone as measured in the formalin test. A  3min swim in 20°C water has also been 
employed in mice (Hart et al., 1983) and rats (Jackson and Kitchen,1989a; Kitchen and 
Pinker, 1990) as an antinociceptive model and has been shown to activate opioid 
systems in its mediation, being attenuated by opioid pi and ô antagonists in the hot plate 
(Hart et al., 1983) and tail immersion tests (Kitchen and Pinker, 1990) respectively. 
However, Vaccarino et al., (1992) reported that antinociception produced in mice by 
the 20°C swim stress in the formalin test is non-opioid in nature since naloxone at a 
dose of Img/kg had no effect on the swim-SIA. Hart et al., (1983) reported that in 
mice, a 30 second swim in 30°C water induced antinociception as measured by acetic 
acid-induced (abdominal constriction) writhing and not by hot-plate test that was 
unaffected by high doses o f naloxone (lOmg/kg) and IC I 154,129 (30mg/kg). This 
suggests that the model employed activates non-opioid system since a lower dose o f 
naloxone (2mg/kg) was effective in reversing morphine (2.5mg/kg) induced inhibition 
o f the acetic acid writhing response (Hart et al., 1983). It thus appears that the 
differential activation o f opioid and non-opioid mechanisms of antinociception by stress 
may depend not only on the parameters but also on the type of pain test employed.
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It is o f interest to note that the swim-stress parameter (3.5min, 2^0), which activated a 
non-opioid system (Bodnar and Sikoszky, 1983), also led in  some animals, to a 
concurrent activation o f opioid and non-opioid antinociceptive systems, with the opioid 
component only being responsive to naloxone antagonism, hence a reduction but not 
complete elimination o f the antinociceptive response (Bodnar and Sikoszky, 1983). A 
particular stressor can therefore activate both opioid and non-opioid pain inhibitory 
systems leading to a higher magnitude of the antinociceptive response than that produced 
by the activation o f a purely opioid or non-opioid system. But, in a collateral inhibition 
model proposed by Kirshgessner et al., (1982), opioid and non-opioid mechanisms of 
antinociception have been viewed as acting in a mutually inh ib itory fashion. 
Kirshgessner et al., (1982), induced antinociception in naloxazone intraventricularly 
pretreated rats with morphine and cold water stress (non-opioid) and found that while 
naloxazone blocked morphine antinociception, it potentiated CWS antinociception. In a 
related study, Grisel et al., (1993) reported that naltrexone enhanced SIA induced by 
CWS and social defeat but morphine antinociception was attenuated by the non-opioid 
(CWS and social defeat) antinociception, a finding which also support the notion that 
opioid and non-opioid mechanisms of SIA interact in an inhibitory fashion. In support 
o f this inhibitory interaction, Tierney et al., (1991), reported that in  mice, a 15sec. 
swim-SIA at room temperature (20-22“C) induced a non-opioid antinociception in the 
ta il-flick test. This was followed by a longer opioid antinociception as a consequence 
o f increased swim duration, but with a complete suppression o f the earlier non-opioid 
component evident after 3min of swim.
Studies into these environmental determinants of stress-induced-antinociception are the 
most common approaches employed to investigate the nature o f in trinsic pain 
suppressive mechanisms. The antinociception induced by the stressors have been 
measured by a wide range o f pain tests (see table 1).
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1.4 ENDOGENOUS OPIOIDS IN  SIA
The antinociceptive properties o f opioids of plant and synthetic origin have long been
reported. Several lines o f evidence which emerged, associating the mechanism of
action o f morphine antinociception to that o f stimulation produced antinociception
(SPA), have led to the notion that the central nervous system might contain endogenous
substances, having antinociceptive properties virtua lly identical to opioids. A
pharmacologically relevant finding that SPA was at least partially antagonised by the
specific opioid antagonist, naloxone (A kil et al., 1976b) and the reported existence o f
stereospecific binding sites for opioids in the central nervous system (Pert and Synder,
1973), were critical to the eventual discovery o f these endogenous substances.
Hughes, (1975) reported the detection from brain extracts o f substances that exhibited
opioid like activity and was followed by the successful isolation and characterisation of
the firs t endogenous molecules (methionine and leucine enkephalins) w ith opioid
activity and high affin ity for opioid receptors (Hughes et al., 1975). Since then, more
than a dozen endogenous peptides with opioid activity have been found. Their
anatomical distribution were found to overlap with sites involved in pain processing
(Lewis et al., 1984). Greater understanding o f the neural and neurochemical
mechanism involved in pain perception was achieved following the discovery o f these
central nervous system substrates whose normal function appears to be pain inhibition.
Three families of the endogenous opioid peptides are currently recognised on the basis
o f their derivation by sequential proteolytic cleavage from three distinct precursor
prohormones: pro enkephalin, froni which the enkephalins are derived;
proopiomelanocortin (POMC) from which B-endorphin is derived; and prodynorphin
from which the dynorphin fam ily o f peptides are derived (Lutz and Pfister,.
1992). See the major endogenous opioid peptides and their 
precursors (figure 2).
Studies have now shown that the endogenous opioid peptides in both the central and 
peripheral nervous system are involved in the phenomenon o f stress-induced 
antinociception, and the three endogenous opioid families are heavily invested in
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systems that regulate the body's responses to stress and can thus be found in  the 
hypothalamus, the pituitary, and the adrenal medulla. It has been shown that the central 
nuclei which regulate autonomic function such as nucleus tractus solitarius, are 
enriched with endogenous opioids and their receptors, suggesting the powerful role o f 
opioids in regulating the organism's response to physiological and environmental 
demands including physical and psychological stress. The autonomic nervous system 
has itself been shown to contain endorphins (Schuttzberg et al., 1978) and opioid 
receptors (Young et al., 1980). The pituitary cells contain both adrenocorticotrophic 
hormone (ACTH) and p-endorphin (Mains et al., 1977) and release them concomitantly 
in response to stress (Guillemin et al., 1977; Rossier et al., 1977). S im ilarly, the 
adrenal medulla has been shown to contain enkephalin-like peptides and to secrete them 
in response to sympathetic activation (Simantov et al., 1977; Viveros et al., 1979). For 
reviews on endogenous opioids and stress see A kil et a l.,(l98^ Szekely,(l99(^.
Various stress models such as immobilisation, footshock, cold exposure and tail pinch 
which can cause opioid dependent antinociception, have been shown to result in  
decreased levels of B-endorphin in the anterior lobe o f the pituitary and a concomitant 
increase in plasma B-endorphin levels (Baizman etal., 1979; Santagostino et al., 1980; 
M illan, 1981; Lim and Fonder, 1983; A kil et al., 1986). Similar observations have 
been demonstrated in animals subjected to acute and chronic swimming (Vaswani et al., 
1988). Studies have also shown that stress induced by brief social deprivation in rats 
results in the activation of hypothalamic enkephalinergic neurones, evidenced by 
increased enkephalin RNA immunoreactivity and a paralleled increase in  met- 
enkephalin-derived peptides. This effect is believed to be responsible fo r the 
antinociception and hypertension that rats show following social isolation (Iglesias et 
al., 1992). In a related study, Przewlocka et al., (1990) have shown that conditioned 
fear which resulted in the development o f antinociception also evoked a marked 
decrease in hypothalamic p-endorphin level and a three-fold increase in the peptide level 
in the plasma. In contrast, the level o f a-neoendorphin in the hypothalamus, pituitary 
and spinal cord were unaltered whereas an increase was observed in the plasma. This
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observation suggests a contribution o f the proopiomelanocortin system in conditioned 
stress-induced antinociception. The prodynorphin system appears to play no important 
role and may explain why the K-agonist, U69,593 does not influence the conditioned 
stress-induced antinociception.
The importance o f peripheral opioid peptides in stress-induced antinociception has been 
shown. For instance levels o f leu- and met-enkephalin were shown to be lowered in 
the adrenal glands due to opioid-mediated cold swim stress antinociception (Vaswani et 
al., (1988). A substantial portion o f footshock (opioid) mediated antinociception is 
also believed to be due to the activation of peripheral endorphins (Chance and Nelson, 
1986), since the antinociception was attenuated by quaternary naloxone methylbromide 
which does not cross the blood-brain barrier. Similarly, Parsons and Herz, (1990) 
reported that in response to cold water swim stress, rats w ith inflamed peripheral 
tissues show an increased paw pressure threshold when pre-treated w ith the 
enkephalinase inhibitors thiorphan and bestatin. The antinociceptive synergy induced 
by these enkepalinase inhibitors was antagonised by quaternary naloxone indicating a 
peripheral site o f action*All these observations suggest the involvement o f endogenous 
opioid peptides in the phenomenon of stress induced antinociception. The changes 
observed in the levels of opioid peptides depends upon the type o f stress applied which 
is believed to affect differentially the synthesis and processing o f various opioid 
precursors (Vaswani etal., 1988).
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Figure 2
Major Endogenous Opioid Peptides and Precursors
Precursors Peptides Structures
Proenkephalin Met-enkephalin Tyr-Gly-Gly-Phe-Met5
Leu-enkephalin Tyr-Gly-Gly-Phe-Leu5
Met-enkephalyl-Arg-Phe T yr-Gly-Gly-Phe-Met-Arg-Phey
Met-enkephalyl-Arg-Gly-Leu T yr-Gly-Gly-Phe-Met-Arg-Gly-Leug
Pro-opio-
melanocortin p-endorphin Tyr-Gly-Qly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Glu-Thr
Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Lys-Asn- 
Ala-His-Lys-Lys-Gly-Gly-Glug i
Prodynorphin a- neo­
endorphin T yr-Gly-Gly-Phe-Leu-Arg-Lys-T yr-Pro-Lys lo
Dynorphin A
(1-17) T yr-Gly-Gly-Phe-Leu-Arg-Arg-Ileu-Arg-Pro-Lys-Leu-
Lys-T rp-Asp-Asn-Glui7
Dynorphin
(1-8) T yr-Gly-Gly-Phe-Leu-Arg-Arg-Ileug
Dynorphin B
(Rimorphin) Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gly-Phe-Lys-Val-Val- 
Thris
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1.5 OPIOID RECEPTORS
Several lines o f evidence indicate that endogenous and exogenous opioids produce their 
antinociceptive effects through activation o f opioid receptors located in the central 
nervous system at both spinal and supraspinal levels. The existence o f multiple opioid 
receptors have been established since the first report by Martin and co-workers, (1976) 
who proposed three types, namely mu (pi), a morphine preferring, kappa ( k ) ,  a 
ketocyclazocine preferring, and a sigma (o) or SKF-10047, N -allyl normetazocine 
preferring opioid receptors. Another opioid receptor named delta (ô) was also 
proposed by Lord et al., (1977), following the discovery of the enkephalins by Hughes 
and coworkers (1975). Subsequent pharmacological investigations in whole animals, 
invitro bioassay systems as well as radioligand-binding studies in cell membrane 
preparations, have confirmed the opioid nature o f pi, k  and ô receptors, w ith a  
receptors being non-opioid in nature, (Mannalack et al., 1986). There is sufficient 
evidence to suggest that each of the three classes of endogenous opioid peptide families 
have preference for a major opioid receptor type,hence the ô-receptor was defined as an 
enkephalin receptor, and the enkephalins are still thought to be the major endogenous 
ligands for this receptor. The k  receptor is like ly to be the receptor fo r the peptides 
derived from prodynorphin, i.e. dynorphin A and B and the neoendorphins. B- 
endorphin appears to be the endogenous ligand for the pi receptors, however the 
enkephalins are likely candidates as well since they have an appreciable affin ity for this 
receptor although less (10 or 20 fold) than for ô receptors, (fo r review see Simon
1991). The opioid receptors belong to the superfamily of G-protein coupled receptors.
In recent years many G-protein coupled receptors (including the three opioid receptors) 
have been cloned and their amino acid sequences have indicated that they comprise of 
seven transmembrane regions. The mouse 0-opioid receptors was recently cloned and 
expressed by Evans et al., (1992) and Kiefer et al., (1992), w ith their amino acid 
sequencing showing the seven transmembrane domains. They were also shown to 
bind compounds selective for ô-receptors with much higher affinities than for and k
selective drugs. Bzdega et al., (1993)also cloned the ô-receptor gene in the mouse brain
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I and detected larger amounts in the pituitary and the pineal glands. They were shown 
to be identical to those cloned by Evans et al., (1992) and Kiefer et al., (1992). The pi- 
receptors from rat brain have also been cloned by Chen et al., (1993a). The same 
group, using the cloned //-receptor cDNA as probe, later identified another clone in the 
rat that is very similar to both //- and Ô-receptor sequences (Chen et al., (1993b). 
Transient expression of this clone in COS-7 cells showed that it encodes a K-opioid 
receptor which is capable o f high affin ity binding to K-selective ligands. W ith the 
continuous development and use o f more selective radioligands fo r labelling the 
recognition sites o f these receptors, evidence now exists fo r the presence o f 
pharmacologically active subtypes and possibly other classes o f opioid receptors.
1.5.1 Opioid Receptor Subtypes
The differential affinity and selectivity of opioid agonists and antagonists observed in 
in vitro  and in vivo animal experimental studies have been used as the basis fo r 
characterising opioid receptors into subtypes. Evidence for the existence o f multiple pi- 
opioid receptors came from studies using selective and long lasting pi\ opioid receptor 
antagonists, such as naloxazone and naloxonazine. These studies'also revealed the role 
o f the //-opioid receptor subtypes in a number o f opioid actions. The //-opioid 
receptors have been divided into two subtypes, the //i^ receptor which binds opioids 
and most enkephalins with similar high affinities, and / /2  receptor which preferentially 
binds to morphine (Goodman and Pasternak, 1985; Pasternak and Wood, 1986). The 
high affinity //% receptors were shown to mediate opioid antinociception while the lower 
affin ity / / 2  sites mediates the respiratory depression, gastrointestinal transit and many 
signs o f physical dependency (Ling et al., 1985; Paul and Pasternak, 1988). 
Characterisation o f the // opioid receptor functions were based on the findings that 
injection o f //% antagonists in animals led to the antagonism of morphine antinociception 
without protection against its respiratory depression. The distinctness o f the / / 1 and //2 
sites have also been revealed through autoradiographic studies (Moskowitz and
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Goodman, 1985) o f the mouse central nervous system using pH ] dihydromorphine 
(DHM) to visualize the total pi sites and p H ] (DHM) w ith [D -A la^, D -Leu^]] 
enkephalin (DADL) for the pi2 sites. Result shows high densities o f pi\-pi2 receptors in 
frontal cortex, nucleus accumbens, rostal striatum, ventral pallidum, ventral P.A.G. 
and laminae 1 and 11 o f the spinal cord. These regions are known to play major roles 
in opioid-induced antinociception. The existence of two ô-receptor subtypes have also 
been proposed (Jiang et al.,1991; Mattia et al., 1991; Sofuoglu et al., 1991). Earlier, 
Shimohigashi et al., (1987), reported that a highly selective ligand for brain ô-opioid 
receptor, a Phe-4-enkephalin analogue, binds to ô-receptors in rat brain tissue but not to 
ô-receptors in the mouse vas deferens. The development o f more selective and stable 
antagonists fo r ô-receptors in recent years have aided the research on ô-receptor 
heterogeneity. Sofuoglu et al., ( 1991), investigated the antagonism of naltriben (NTB) 
and naltrindole (NTI) on the antinociceptive effects o f the ô-opioid receptor agonists 
[(D-Pen2,D-Pen^,)] enkephalin , (DPDPE), [(D-Ser2,Leu^,Thr^)] enkephalin , 
(DSLET) and [(D-Ala^,D-Leu^)] enkephalin , (DADLE). Sofuoglu et al., (1991) 
found that NTB was more effective in antagonising DSLET than DPDPE supraspinal 
antinociception and that NTB antagonism of DSLET antinociception was even greater at 
spinal than supraspinal site. Sofuoglu et al., (1991) also found that NTB had no effect 
on DPDPE spinal antinociception and there was no development o f cross tolerance 
between DSLET and DPDPE antinociception. Sofuoglu et al., (1991) therefore 
suggested that the action o f DSLET which is said to have some //-opioid activity , is 
entirely due to ô-receptor activation since NTB had no effect on spinal and supraspinal 
action of [D-Ala^» MePhef^ »Gly(ol)^] enkephalin, (DAGO) and morphine sulphate. In 
fact pretreatment o f the mouse with the irreversible //-op io id  antagonist, 6- 
funaltrexamine, (6-FNA), served to increase the ability o f NTB to antagonise DSLET 
spinal antinociception but did not affect NTB's indifference to DPDPE spinal 
antinociception. Sofuoglu et al., (1991) concluded therefore that the action o f DSLET 
and DPDPE may be mediated via different ô-opioid receptors. Radioligand binding and 
competition binding studies (Sofuoglu et al., 1992) among various ô-opioid receptor
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agonists and antagonists have demonstrated the existence o f Ô-opioid receptor 
subtypes.
In a related study, Jiang et al., (1991) have shown that while [D-Ala^] deltorphin II 
(D E LTII), DSLET and DPDPE essentially induce ô-opioid mediated antinociception in 
mice, their profile o f action are distinguishable with tialtrindole 5 '-Isothyocyanate, 
5'NTII) and [(D-Ala^, Leu^, Cys^] enkephalin , (DALCE) antagonism. Jiang et al., 
(1991) reported that DALCE which has a mixed agonist/antagonist action, significantly 
blocked the antinociception in mice induced by icv DPDPE but not by icv DELT II. 
However the antagonist, 5'NTII attenuated icv DELT II antinociception but not that of 
icv DPDPE. In addition, 5'NTII antagonised DSLET antinociception more effectively 
in B-FNA pretreated mice and the antagonism is similar in profile to that seen w ith 
DELT II. In contrast, DALCE pretreatment failed to block the antinociceptive actions 
o f DSLET. Jiang et al., (1991) suggested that the differential antagonism o f icv 
DPDPE and DELT II seen after icv DALCE and 5'NTII pretreatment, is due to the 
activation o f different Ô-opioid receptors by the agonists. Furthermore, DSLET 
appears to induce antinociception at the same site as DELT II, but at a different ô-opioid 
receptor site acted upon by DPDPE. Other evidence in support o f ô-receptor 
heterogeneity comes from tolerance and cross tolerance studies (Mattia et al., 1991) in 
which mice pretreated twice daily fo r three days w ith icv DPDPE induced 
antinociceptive tolerance to icv DPDPE but not to icv DELT II antinociception. 
Similarly, icv DELT II pretreatment induced DELT II but not DPDPE antinociceptive 
tolerance, suggestive of the agonists’activity at different receptor sites.
Extending the findings of Jiang et al., (l991) that supraspinal (icv) DELT II  and 
DSLET antinociception are 5'NTII sensitive (ô%-receptors) and supraspinal DPDPE is 
DALCE sensitive (ôi-receptors), Mattia et al., (1992) studied in mice the ô-opioid 
mediated antinociception at spinal level. Results indicate that spinal (i.t.) DELT II is 
also sensitive to i.t. 5'NTII antagonism. Sim ilarly, i.t. DPDPE and DALCE are 
sensitive to i.t. 5'NTII antagonism although a higher dose (10 fold) was needed to 
produce DPDPE antagonism equal to that of DELT II. In contrast, i.L DALCE failed to
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block DELT II, DPDPE or DALCE-induced antinociception, suggesting that the ô- 
receptors involved in spinal antinociception is the 5'NTII sensitive (Ô2 ) type. Mattia et 
al., (1992) have pointed to the possibility that the previous reports on ô-receptor 
heterogeneity (Jiang et al., 1991; Mattia et al., 1991, 1992; Sofuoglu et al., 1991) may 
be test and species specific and have suggested therefore that studies involving other 
species and nociceptive paradigms be extended cautiously. In related studies using the 
tail immersion test, it has been shown that selective ô-agonists elicit antinociception in 
post-weanling rats which are differentially antagonised by ô-receptor antagonists 
(Crook et al., 1992; 1993). Antagonist studies revealed that a low dose o f NTI 
(0.01 mg/kg) is sufficient to produce a significant attenuation o f DPDPE and DSLET 
antinociception. However, in respect o f DELT I antinociception, a much higher 
concentration of NTI (ICX) fold) was found to be necessary to produce antagonism 
equivalent to that of DPDPE and DSLET (Crook et al., 1992). This differential effect 
o f NTI on the three opioid agonists coupled with the lower sensitivity o f response to 
DELT I antinociception suggest a ô-receptor heterogeneity in the rat as in the mouse. 
Furthermore, DELT I appear to exert its antinociceptive effects at a different receptor 
subtype from DPDPE and DSLET (Crook et al., 1992). In a related study. Crook et 
al., (1993) have shown that low doses (0.5 and 5///kg) o f the ô-receptor antagonist 
naltriben (NTB) partially and completely abolished the antinociception induced in post­
weanling rats by the ô-agonist, DSLET. A t these doses the antinociception induced by 
DPDPE and DELT I were unaffected and a much higher dose (50//g/kg) was needed to 
fu lly  reverse the antinociception induced by all three agonists. Thus, evidence now 
available from studies in both rats and mice have revealed the existence of heterogenous 
ô-receptor subtypes.
Like the p  and ô-receptors, a weight of evidence exists to suggest that the K-opioid 
receptors also represent a population of at least two distinct subtypes and there have 
been suggestions that up to four of the K-subtypes exists. Evidence for the multiplicity 
of K binding sites has also been based on physiological/pharmacological studies as well 
as ligand binding experiments. Perhaps the first reported physiological/pharmacological
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evidence for K-receptor heterogeneity was the observation that the increase and decrease 
in plasma corticosterone and thyroid stimulating hormone respectively caused by the k -  
agonists (U-50,488H and EKC) were differentially antagonised by WIN-444,41-3, a 
compound known to be selective for K-receptors (Iyengar et al., 1986). Further 
physiological evidence was indicated by the effect of two K-agonists on the modulation 
o f action potential o f mouse dorsal root ganglia neurones. U-50,488H enhanced the 
opening of voltage sensitive Ca^^ channels and dynorphin closed the voltage sensitive 
K+ channels. These differential effects indicate a possible mediation via different 
receptors (Shen and Crain, 1989). More recently, studies on K-induced antinociception 
has been used to demonstrate the existence of K-receptor subtypes using opioid ligands 
such as the mixed opioid agonist/antagonist, naloxone-benzoylhydrazone (Gistrak et 
al., 1989; Paul et al., 1990), nalorphine (Paul et al., 1991) and levophanol (Tive et al.,
1992). For review on evidence for the different K-opioid receptor subtypes see 
Wollemann et al.,^993).
1.5.2 Opioid Receptors and Antinociception
Opioid receptor involvement in the control of nociception is complex. The contribution 
of one or more o f the subtypes depends among others, upon the quality o f nociceptive 
stimulus, the species of animal being tested, as well as the constitution o f receptors at 
the different levels of the neuroaxis. Stimuli such as thermal, electrical or mechanical 
have been shown to activate pi, k  and Ô opioid receptors differentially. Moreover, 
different opioid receptor constitution have been identified in different tissues and 
different species o f all vertebrates (Robson et al., 1985; Yobum et al., 1991). pi 
receptors are particularly abundant in structures involved in the transmission o f 
nociceptive messages (Moskowtiz and Goodman, 1985), such as the posterior horn of 
the spinal cord, spinal cord nucleus of the 5th cranial nerve, periaqueductal gray matter 
(PAG), nucleus raphe magnus (NRM) and thalamus fo r which reason, the 
antinociceptive activity o f opioids was in itia lly  attributed to the activation o f //- 
receptors. However, it is now known that opioid antinociception is also mediated 
through the activation o f k -  (Piercey et al., 1982; Von Voigtlander et al., 1983) and ô-
35
(Ling et al., 1983; Yaksh, 1983; ) receptors, and the occurrence o f 0-and k -  receptors 
in regions o f the CNS believed to play a major role in antinociceptive processes have 
been shown (Mansour et al., 1987; Morris et al., 1988).
Several reports have emerged giving detailed assessment o f the contributions o f the 
opioid receptors and their subtypes in the mediation o f spinal and supraspinal 
antinociception. In a micro injection study in rat, Bodnar et al., (1988), found that both 
morphine and DSLET were capable of inducing antinociception in periaqueductal gray, 
locus coeruleus, nucleus raphe magnus and nucleus reticularis gigantocellularis which 
was effectively antagonised by the //^-selective antagonist, naloxonazine. Bodnar et 
al., (1988), suggested a supraspinal //^-receptor mechanism since the ô-ligand DPDPE 
which does not interact with //^-receptors fails to elicit antinodception in either the PAG 
or locus coeruleus. A  //i-receptor involvement in supraspinal antinociception was also 
reported by Heyman et al., (1988) who demonstrated that naloxonazine attenuated the 
antinociception induced by icv but not i.t. administered morphine and DAGO. 
However, in the mediation of spinal antinociception, Paul et al., (1989) have shown 
that in addition to the ô-receptors, the /<2 receptors but not / / j,  might be involved. 
They found that both DAGO and DSLET induced supraspinal and spinal 
antinociception, but naloxonazine attenuated only the supraspinal antinociception. The 
DAGO spinal antinociception was however antagonised by naloxone and 6-FNA. 
Since spinal DAGO was insensitive to naloxonazine, ruling out a mechanism ,Paul 
et al., (1989) suggested that //2 -receptors may have a role in e lic iting spinal 
antinociception. The works o f Heyman et al., (1987) in mice have provided a strong 
and direct evidence for the involvement of supraspinal sites in addition to the spinal ô- 
receptors in the mediation o f antinociception in tests where heat is employed as the 
noxious stimulus. They have shown that icv or i.t. 6-FNA pretreatment resulted in the 
attenuation o f icv and i.t. //-opioids (DAGO; morphine) antinociception w ithout 
affecting icv or i.t. DPDPE antinociception. Sim ilarly, administration o f the ô- 
antagonist, IC l 174, 864 (A llyh-Tyr-A ib-Aib-Phe-Leu-O H) by the same routes 
produced a dose-related attenuation o f icv and i.t. DPDPE, but did not alter the icv or
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i.t. //-opioid antinodception. Heyman et al., (1987) believed that these findings 
suggest ' an intimate and separate role of ô-opioid receptors from that o f //-receptors in 
the mediation of supraspinal and spinal antinodception. However, it is worth noting 
that interactions between //- and ô-receptors in antinociception have earlier been 
reported by Barrett and Vaught, (1982), who found that relatively selective 0-ligands 
([leu enkephalin and its analogues), produced potent antinodception and also 
potentiated at sub antinociceptive doses, morphine-induced antinociception, indicating 
some interactions between //- and ô-receptors. Thus, in addition to distinct //- and 6- 
receptors, a complex of //- and ô- (//-ô) receptors may exist by which morphine (//- 
receptor mediated) antinociception is modulated (Vaught et al., 1982). Further 
evidence that morphine antinociception could be modulated by ô-receptors was 
provided by the observations that the ô-antagonist, IC I 174, 864, prevented both the 
increase and decrease o f morphine antinociceptive potency induced by DPDPE and 
[DAla2, Met^] enkephalinamide (DAMA) respectively (Heyman et al., 1986). The 
existence o f //-ô receptor complex has again been supported by Heyman et al., 
(1989), who found that 6-FNA, like the ô-antagonist, IC I 174,864, also prevented the 
ability o f the ô-agonists (DPDPE and DAMA) to modulate morphine antinociception. A  
related observation (Miaskowski et al., 1991) that ICI 174, 864 attenuated the 
antinociceptive action o f DPDPE and not o f DAGO and that the simultaneous 
administration o f DAGO and DPDPE produced synergy, suggests that the two 
population o f receptors (// and ô ) on the same or different neurones interact w ith one 
another to contribute in the mediation of supraspinal antinociception. It has recently 
been suggested (Miaskowski and Levin, 1992) that spinal antinociception can be 
modulated by supraspinal opioids through interactions that may occur between 
brainstem and spinal opioid receptor sites. This suggestion was based on the finding 
that the spinal ô (DPDPE) and k  (U50, 488H) opioid antinociception were markedly 
enhanced by low doses o f supraspinal //- (DAGO) and Ô- (DPDPE) opioids although 
i.t. DAGO antinociception was in contrast, markedly antagonised by low doses o f icv 
DAGO and DPDPE.
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Inspite o f the presence of k  binding sites in brain regions vital to antinociception 
(Mansour et al, 1987), it has frequently been claimed that K-agonists do not e lic it 
antinociception via actions in the brain (Spampinato and Candeletti, 1985; Castillo et 
al., 1986; Schmauss, 1987; Miaskowski et al., 1991). However, preliminary studies 
have shown that the K-agonist U50,488H wasi antinociceptive against noxious 
pressure upon application into the brain (Czlonkowski et al., 1987; Leighton et al., 
1988). In a comparative antinociceptive study i using heat and pressure stimuli in  rats, 
M illan et al., (1989), found that in addition to their spinal actions, intraventricular 
application o f pi (DAGO; Morphine) and k  (U-69, 593; U50,488H; bremazocine; 
tifluadom) agonists produced a dose dependent antinociception that was: antagonised 
by naltrexone (preferential for pi agonists) and nor-binaltorphimine, (Nor-BNI) (for k )  
respectively, a finding which strongly implicates supraspinal K-receptors in  
antinodception.
1.5.3 Opioid Receptors and SIA
Studies on stress-induced-antinociception have additionally uncovered the role o f 
m ultiple opioid systems in inhibition o f pain responsiveness as a function o f 
environmental variables. Some evidence shows that the opioid component o f SIA for 
most stressors involves pi and ô receptors. For instance, the effect o f footshock and 
swim stress were shown to be abolished completely by a low dose (100//g) o f 
naloxone, which suggests that the receptors involved are likely to be o f the pi or the ô 
type (Carmody and Cooper, 1987). W ith the availability and trials o f relatively 
selective ô-antagonists such as ICI, 154,129; ICI, 174,864 and naltrindole on SIA, ô- 
receptors have also been implicated in both mice (Hart et al., 1983; 1985) and adult rats 
(Jackson and Kitchen 1989a and b; Jackson et al., 1989). The release o f opioid 
peptides Such as 6-endorphin by a variety of antinociception producing stressors has 
been shown (A kil et al., 1986). 6-endorphin has been shown to exhibit equivalent 
activity at pi and ô receptors (Paterson et al., 1983), and could mediate SIA in both 
adult and neonate animals depending upon the opioid-receptor constitution. Previous 
studies have shown that in the neonatal (20 day old preweaned) rats, naloxone but not
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naltrindole antagonised swim-SIA (Kitchen and Pinker, 1990), which suggests that p i-
receptors mediated this effect, inspite o f the presence of about 75% o f ô binding sites in 
brain tissues at this age (McDowell and Kitchen, 1986). In the postweanling (25 day 
old and adult) rat however, naltrindole effectively antagonised the SIA, suggesting 
mediation by ô-receptors (Kitchen and Pinker, 1990). It also suggests that the sub 
population o f ô-receptors which develops in the postweanling period in the rat may be 
responsible for mediating the SIA.
Recently, Vanderah et al., (1992) suggested that the ô-receptor-m ediated 
antinociceptive effect o f cold water swim stress in mice involves the activation o f 0 2 - 
receptors. Vanderah and co-workers found that SIA (5°C, 3 min) was antagonised by 
naloxone and by the ô-antagonist IC I 174, 864. The stress-response was also 
antagonised by the opioid Ô2 -antagonist, 5'NTII , but not by the ô  ^(DALCE), pi (6- 
FNA) or K (Nor-BNI) antagonists. Furthermore, tolerance and cross-tolerance 
develops between the antinociceptive effects of cold water stress and the Ô2  agonist, [D- 
A la2] deltorphin, but not between the cold water stress and pi (DAGO) or the 
predominantly Ôj agonist, DPDPE.
It has been suggested that K-receptors are im p lica ted  in  som e form s o f SIA. Panerai e t 
a l., (1984) reported that K -receptor antagonists (MR 1452 and MR 2266) reversed the  
n o n -o p io id  but not the o p io id  antinociception  induced b y  continuous and in te rm itte n t 
footshock stress respectively  and suggested that K -receptors m ig h t be im p o rtan t in  the  
m ed iatio n  o f n o n -o p io id  ra th er than o p io id  SIA. K -receptor in vo lvem en t in  the  SIA 
trig g ered  by a  type o f psychological stress in  m ice as m easured by the ta il p inch  test 
have also  been reported  (Takahash i e t a l., 1990). A recent rep o rt has in d icated  that 
spinal K -op io id  receptors are invo lved  in  the m ediation o f a type o f fo o t shock induced
antinociception in mice, because the resultant antinociception was antagonised by 
systemically and intrathecal 1 y administered K-selective antagonist, nor- 
binaltorphimine (Menendez et al., 1993).
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1.6 NON-OPIOID RECEPTORS IN ANTINOCICEPTTQN
The lack o f reversal o f some SIA by opioid antagonists shows that neurochemicals 
other than opioids might be involved in the mediation o f antinociception. Earlier 
studies although inconclusive, have implicated histamine (Lewis et al., 1984), 
dopamine and serotonin (Huston et al., 1984) and acetylcholine (Watkins et al., 1984) 
as neurochemical substrates mediating the non-opioid forms o f stress antinociception. 
However, details of the neuronal pathways involved in this phenomenon are still being 
investigated. Sperber et al., (1986) have reported a cholinergic involvement in two 
forms o f SIA. Sperber et al., (1986), found that the muscarinic receptor antagonists, 
scopolamine and methylscopolamine blocked non-opioid cold water (2°C, 3.5min) 
swim-SIA in  rats and potentiated the opioid-sensitive 2-deoxy-d-glucose 
antinociception. Furthermore, the dose dependent reduction of pilocarpine (muscarinic 
agonist) antinociception by the muscarinic receptor antagonists (scopolamine and 
methylscopolamine) was seen to differ in pattern from that o f the stressors, which 
suggest a heterogeneity in muscarinic receptor modulation o f the d ifferent 
antinociceptive responses. Sperber et al., (1986) believed that the observed changes 
induced by scopolamine and methylscopolamine upon the antinociceptive responses o f 
each stressor is due to changes in pain inhibitory circuits. Muscarinic receptor 
involvement in the naloxone-sensitive SIA was reported by Hart and Yadav, (1985) 
who found that swim-SIA at 20°C for 3min in mice was dose-dependantly reduced by 
hyoscine. In a related experiment. Hart and Oluyomi, (1986) found no evidence for the 
involvement o f acetylcholine in the naloxone insensitive model (30sec WWS, 3CPC) o f 
SIA since the resultant SIA was unaffected by atropine methyl nitrate (5,10mg/kg) or 
atropine sulphate ((l,5,10mg/kg) administered 15min priorto the swim. Spear et al.,
(1985) have shown that administration of the 5-HT agonist, quipazine, resulted in 
antinociception which was blocked by pretreatment w ith the 5-HT antagonist, 
metergoline. Sim ilarly, environmental stressors such as 24hr food and maternal 
deprivation, which resulted in significant increases in 5-HT and its metabolite 5- 
hydroxy-indole-acetic acid (5-HIAA), in rats also induced antinociception that was
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blocked by metergoline. In a related study with neonate rats, Enters and Spear, (1988), 
have shown that metergoline was also effective in attenuating morphine antinociception 
as well as antinociception induced by the stress o f isolation from siblings and the dam. 
On the contrary, naloxone was shown to be ineffective in blocking antinociception 
induced by quipazine and by food/dam deprivation. Enters and Spear, (1988), 
suggested therefore, that in the neonate as in adult, 5-HT modulation o f nociception 
appears to occur “downstream” from the opioid systems serving to regulate nociception 
following both drug and environmental alterations in pain sensitivity. K ie fd  et al., 
(1989) evaluated the role of 5-HT receptor subtypes in mediating opioid (ICWS) and 
non-opioid (CCWS) forms of cold water swim-SIA in the rats. K ie f e l;t al., (1989) 
reported that i.t. administration o f methysergide, a non specific 5-HT antagonist, 
blocks the opioid (ICWS) and not the non-opioid (CCWS) mediated antinociception. 
However, KiefW et al., (1989) found that systemic administration o f 5-HT% receptor 
antagonists (pirenpirone and ketanserin) were more effective in blocking the non-opioid 
(CCWS) than the opioid (ICWS) antinociception. This suggests a d ifferentia l 
serotonergic modulation of the two forms of swim-SIA with the opioid-mediated form 
acting through spinal 5-HTi receptors and the non-opioid mediated form through 
supraspinal 5-HT2 receptors. Support for the involvement o f 5-HT receptor 
mechanisms in antinociception came from the works of Rodgers and Shepherd (1988, 
1989,1990), who showed that the antinociceptive reaction to defeat experience in mice 
was blocked by a range o f 5-H T ia receptor ligands. In addition, Rodgers et al., 
(1992a), explored the involvement of 5 -HT3 receptors in the adaptive inhibition o f non­
opioid defensive antinociception. Results obtained indicate that defensive 
antinociception in male mice was attenuated by the 5 -HT3 antagonists, ICS205-930, 
MDL72222, MDL73147EF and MDL72699 which suggest that 5 -HT3  receptor 
mechanism may also have an important modulatory role in certain forms o f stress 
antinociception.
Studies with dopamine agonists and antagonists have shown that dopamine has an 
inverse relationship with SIA. Hart and Oluyomi, (1989), reported that the dopamine
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agonists apomorphine (0.05 and 0.5mg/kg) had no effect in either unstressed or 
stressed (3min swim, 20°C water) mice. A t a higher dose, apomorphine (5mg/kg) 
induced a shorter reaction time in the hot plate and, significantly reduced SIA in  
stressed mice. Dopamine (10//g icv) and L-Dopa (200mg/kg) had a similar effect with 
apomorphine (5mg/kg). However, a lower dose of dopamine (l//g /kg) significantly 
increased SIA. The dopamine antagonists, haloperidol and pimozide (0.1 and Img/kg) 
also increased SIA significantly especially by icv route, and had no effect in unstressed 
mice. The dopamine agonists and antagonists showed a similar pattern of activity when 
the intensity of stress was increased to 3min, 2®C. However, in the non-opioid model, 
o f SIA, the role o f dopamine could not be assessed since a ll the agents 
(agonists/antagonists) reduced acetic-acid induced abdominal constriction (Hart and 
Oluyomi, 1989). Using a range of a-adrenoceptor agonists and antagonists, Oluyomi 
and Hart, ( 1990) investigated the possible involvement o f a-adrenergic receptors in 
swim-SIA in mice. Oluyomi and Hart, (1990), reported that ai-adrenoceptors are not 
involved in the antinociception induced by a 30s warm water (30°C) swim-stress 
(WWS), a naloxone insensitive model (Hart et al., 1983). This is because indoramin 
which has a i antagonist activity similar to prazosin had no significant effect on the 
antinociception. Involvement o f «2 adrenoceptors in this naloxone i n s e n s i t i v e  mo d e l  was 
however evident since WWS-SIA was reversed by the «2 adrenoceptor antagonists, 
idazoxan and yohimbine. The finding that clonidine ( 0 2 -adrenoceptor agonist) 
induced increase in hot plate latency was also antagonised by yohimbine, has provided 
additional support for a 2 -adrenoceptor involvement. Evidence for ai-adrenoceptor 
involvement in antinociception was shown by the enhancement o f naloxone sensitive (3 
min, 20°C) swim-SIA by noradrenaline, an effect antagonised by both a i-  (prazosin) 
and «2- (idazoxan, yohimbine) adrenoceptor antagonists (Oluyomi and Hart, 1990).
Additional support fo r the participation of a 2-adrenoceptor mechanisms in the 
modulation o f swim-SIA in mice comes from the works o f Tokuyama et al., (1991).
In  this study, both forced swim-stress and clonidine antinociception were dose 
dependantly antagonised by yohimbine, exhibited cross tolerance and had a mutual 
potentiating effect on their antinociceptive activity. .
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Earlier experiment with selective antagonists WB4101 (a i) and idazoxan (0 2 ) [has 
demonstrated that antinociception in rats may be mediated sim ilarly by a i and 02- 
adrenoceptors (Hayes et al., 1986). In another study conducted by Oluyomi and Hart,
(1991), the role of histamine agonists and antagonists in the naloxone resistant and 
sensitive models o f swim SIA was investigated. They showed that histamine and 
dimapiit were antinociceptive especially after intraventricular administration. Histamine 
Hi-receptor antagonists, diphenhydramine, promethazine and mepyramine as well as 
large doses o f histamine H2-receptor antagonists, cimetidine and zolantidine were also 
antinociceptive. In this experiment, a direct involvement of histamine in the naloxone 
insensitive WWS-SIA could not be made due to the intrinsic activity o f the antagonists 
and their inability to antagonise histamine antinociception. Oluyomi and Hart, (1991) 
however, suggested that in the naloxone sensitive swim-SIA, indirect evidence for the 
involvement o f histamine exists since pretreatment with H i or H2  receptor antagonist 
produced an enhancement o f SIA that is unrelated to the antinociceptive activity o f the 
antagonists. Furthermore, histamine, dimapiit and the Hg-receptor agonist, a-methyl 
histamine, also produced a significant enhancement o f SIA which was more 
pronounced when the drug was administered by the intraventricular route. Evidence 
for the involvement of histamine is therefore based on the ability o f histamine agonists 
and antagonists to enhance SIA rather than by classical inhibition of the response by 
selective antagonists. In another study Hart and Oluyomi, (1990) have shown that 
arginine vasopressin, a non-opioid peptide is antinociceptive in  mice after 
intraperitoneal (i.p.) and intracerebroventricular (icv) injection but appears to have no 
modulatory effect on either the naloxone sensitive or insensitive models o f swim-SIA. 
They suggested that the antinociceptive action of vasopressin is  mediated via the 
vasopressin (V i) receptors since the antinociception was antagonised by i.p. and icv 
administration o f deamino (CH2)5 Tyr (Me) arginine vasopressin, an agent believed to 
be a selective antagonist of vasopressin (Vi) receptors (Mannin and Sawyer, 1984).
Vaccarino et al., (1992) reported that in mice, NMDA receptors are involved in the 
mediation o f the non-opioid 3min (20“C and 32"C) swim-SIA as measured by the
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formalin test, since the NMDA receptor antagonist, MK-801 completely blocked the 
resultant SIA. Although the SIA-models employed has a predominantly opioid 
component, Vaccarino et al., (1992) believed that the effect o f MK-801 are not 
mediated via opioid receptors since the antagonist had no effect on morphine 
antinodception.
Although SIA systems have generally been conceptualised as either opioid or non­
opioid, some reports have emerged which suggest that both opioid and non-opioid 
antinociceptive systems may infact be opioid at the level of the spinal cord. Watkins et 
al., (1992), have demonstrated that the three well accepted forms o f non-opioid SIA, 
tail shock, hind paw footshock and cold water SIA were blocked by combined 
intrathecal administration of pi (Cys^'Tyi^-Om^-Pen^-amide, CTOP), ô (naltrindole) 
and K (binaltorphimine) opioid receptor antagonists. Furthermore, combined blockade 
of pi and K, as well as pi and ô, but not ô and k  receptors also blocks the two forms o f 
SIA. Thus, SIA phenomena previously thought to be non-opioid appear to involve 
parallel activation o f multiple spinal opioid processes. These findings suggest the need 
for a fundamental shift in conceptualisations regarding the organisation and function of 
pain modulatory systems (Watkins et al., 1992). ^
1.7 BENZODIAZEPINES AND OPIOIDS
A number o f associations between the pharmacological effects o f the benzodiazepines 
and opioids have been made at clinical, physiological and molecular level. The 
benzodiazepines bind to specific high affin ity sites in the central nervous system 
(Mohler and Okada, 1977; Squires and Braestrup, 1977) and are known to facilitate the 
a c t io n ;  ; o f gamma-dmino-butyric dpid (GABA), an inhib itory transmitter 
throughout the CNS This action probably constitutes the primary mechanisms 
underlying the characteristic property of this class of drug (Lippa et al., 1977; Tallman 
et al., 1980). Two types of benzodiazepine receptors in the CNS. have been identified 
and documented by several authors, termed BZD type I and BZD type II receptors
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respectively (Squires et al., 1979; Gee and Yamamura, 1982; N ichoff et al., 1983). 
Benzodiazepines are among the most widely used therapeutic agents available today and 
their abuse potential is substantial. Opioid drugs, like the benzodiazepines, exhibit 
most o f their pharmacological actions such as the control o f pain, changes in mood as 
well as psychological dependence, through the central nervous system. Their actions 
are also known to be mediated via specific receptors and the existence o f endogenous 
ligands (the opioid peptides) that activate opioid receptors is well known. Chronic 
exposure of humans and animals to opioids (Zangon et al., 1982) and benzodiazepines 
(Cagiano et al., 1990), is associated with various degrees o f drug dependency and 
significant behavioural and biochemical alterations that could affect the offspring, some 
o f which may persist for years or into adulthood.
There is a striking correspondence between the influence exerted by benzodiazepines 
and endogenous as well as exogenous opioids upon many behaviours and autonomic 
functions (M illan and Duka, 1981), and there have been reports o f marked interactions 
between benzodiazepines and endogenous opioid activity (Watanabe et al., 1983);
> :> Behavioural evidence has also pointed to a possible link between benzodiazepine 
and opioid mechanisms o f action which may have both theoretical and clinical 
implications (Cooper, 1983c). Further, the behavioural and central effects o f 
benzodiazepines may involve activation o f endogenous opioid mechanisms (Cooper, 
1982a). For instance the sedative and muscle relaxant effects o f benzodiazepines are 
shared by opioids. It has also been suggested that exogenous and endogenous opioids 
possess significant anxiolytic properties and that endogenous ligands for both opioids 
and benzodiazepines are mobilised in conditions involving anxiety, fear and other 
stressors (for review see M illan and Duka, 1981). It has recently been shown (Tripp 
and Me Naughton, 1992) that endogenous opioid systems mediate the anxiolytic 
actions o f benzodiazepines especially in animals that are adapting to a recently 
introduced conflict. Interactions between opioids and benzodiazepines on locomotion 
have also been reported. Nowakowska and Chodera, (1991) found that a single dose 
o f naloxone counteracted both the reduced as well as augmented locomotor activity in
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rats caused by acute and chronic administration of nitrazepam respectively. A  previous 
study in mice (Rodgers et al, 1985) has shown that naloxone enhanced the depressant 
effects o f chlordiazepoxide on locomotor activity. On ingestional behaviour, opioid 
agonists and benzodiazepines have been shown to stimulate appetite and water 
consumption in a variety o f animals and the effects o f benzodiazepines on this 
behaviour is believed to be linked with a mechanism that also involves the opioid 
system (for a review see Cooper 1983c). Jackson and Sewell, (1984) have 
reported that tifluadom (an opioid benzodiazepine) induced food intake is mediated 
principally via interaction w ith k  and or pi receptors rather than benzodiazepine 
receptors. Tifluadom induced feeding was blocked by the pi (naloxone, naltrexone) 
and K (M r 1452 and M r 2266) but not by the ô (ICI 154, 129) or benzodiazepine 
(R015-1788) receptor antagonists. Other reports have also indicated that naloxone did 
suppress partially or completely the increased food consumption elicited in satiated 
animals by diazepam (B irk and Noble, 1981) and the increased drinking induced by 
chlordiazepoxide (Cooper, 1982a and b). There are several reported interactions 
between opioids and benzodiazepines upon pain modulatory systems in both man and 
animal some of which are known to have important pharmacological and clinical 
implications, (For review see section 1.8).
1.8 BENZODIAZEPINES AND PAIN
1.8.1 Introduction
Since their introduction in the early 1960s, the benzodiazepines have been widely used 
for their anxiolytic and sedative effects (Harris, 1960) and for their muscle relaxant 
property (Hollister et al., 1981). This pharmacological profile o f action offers the 
benzodiazepines an important place in therapeutics and in addition they are extensively 
used in  anaesthesiology as well as in the management o f chronic pain. The 
involvement o f benzodiazepines in pain mechanisms and their modulation is still to be
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fu lly  elucidated since there are many conflicting reports from clinical and experimental 
studies.
1.8.2 Effects of Benzodiazepines on Nociceptive Responses
In animal studies, a variety o f effects o f benzodiazepines on responses to painful 
stimuli (nociception) have been reported. Several studies in both mice and rats, using 
various nociceptive tests (mostly thermal), have been studied. Most studies w ith some 
notable exceptions (Table 2) have indicated that the benzodiazepines w ithin their 
therapeutic range do not possess antinociceptive action on their own. Zambotti et al.,
(1991), suggested that the discrepancies in the effects o f benzodiazepines on 
nociception could be due to differences in testing protocols, whilst Clavier et al.,
(1992) also suggested that different approaches to nociceptive studies (behavioural, 
biochemical, electrophysiological) could account for some of the observed differences 
in results. For instance, Zambotti et al., (1991) noted that the very short interval 
between two successive determinations o f antinociceptive responses used in  some 
studies, produced tolerance to the same thermal stimulus. The apparent antinociception 
reported by others may be in part due to the ability o f benzodiazepines to affect motor 
activity. Rosland et al., (1987) shared the view that the sedative and muscle-relaxing 
effects o f benzodiazepines may influence the interpretation o f tests based on motor 
responses (such as nociceptive tests) and may explain why different conclusions have 
been reached in different studies. Others have reported a hyperalgesia in the mouse 
using various doses of diazepam in a constant temperature hot-plate test with no effects 
in the ta il-flick  and increasing temperature hot-plate tests (Rosland et al., 1987) and 
suggest that the hyperalgesic effect seen may be due to reduced stress antinociception 
since the hyperalgesia is not observed in animals adapted to the test apparatus. The 
same group (Rosland and Hole, 1990a) using a variety o f benzodiazepines at doses that 
also induced significant motor impairment demonstrated increased response latencies in 
a hot-plate test. These drugs produced no effect when lower doses were used, 
suggesting that their antinociceptive effect only at high doses is related to the
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impairment o f motor function. This view had been proposed earlier by Walsh et al.,
(1986), who also found that the dose-dependent increases in hot-plate response 
latencies of chlordiazepoxide and not of flumazenil (a central benzodiazepine-receptor 
antagonist) appeared to be related to depressant effects of the drug on motor activity. 
Similarly, Yanez et al., (1990), reported a dose-dependent increase in ta il-flick and hot­
plate response latencies of intrathecal midazolam but with a clear motor dysfunction at 
larger doses which made the assessment of antinociceptive effect difficult. Contrary to 
these findings, Kunchandy and Kulkami, (1987), reported that the antinociceptive 
effect o f central type benzodiazepine-receptor agonists is not related to their motor 
effects by showing that mouse reflex ta il-flick was not affected by the antinociceptive 
dose (lOmg/kg) of diazepam.
Differences in routes o f administration o f the benzodiazepines used in different studies 
have also been suggested to account for the variability in effects. N iv et al., (1988) 
found midazolam to be hyperalgesic when injected intraperitoneally (i.p.) but was 
antinociceptive by intrathecal (i.t.) route. Similarly, Zambotti et al., (1991) have 
shown that intraperitoneal injection o f diazepam elicits an increase in ta il-flick latency 
but failed to do so when injected intracerebroventricularly (i.c.v.). Although the 
hyperalgesic effect of i.p. midazolam (Niv et al., 1988) was not in agreement w ith 
similar studies involving benzodiazepines in mice (Rosland et al., 1987; Rosland et al., 
1990; Golombek 1991) and rats (Kunchandy and Kulkami, 1987; Zambotti et al., 
1991), these reports (Niv et al., 1988; Zambotti etal., 1991) emphasise the importance 
o f routes o f drug administration in assessing the effects o f benzodiazepines on 
nociceptive latencies. While the differences in some studies may be explained by 
differences in experimental protocols, others are not. For example, using the hot plate 
test Matla et al., (1982) reported that intraperitoneal injection of diazepam (4mg/kg i.p.) 
was without effect in m ice whilst an increase in hot-plate response latency in m ice 
was reported by Kavaliers and Innes, (1988) using a similar dose o f diazepam. Others 
have shown that a lower dose (Img/kg i.p.) of diazepam elicits an increase in ta il-flick 
latency in rats (Zambotti et al., 1991), but a higher dose (2mg/kg i.p.) o f diazepam
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(Rovati et al., 1990) was ineffective. Whilst the preceding discussion has alluded to 
reasons for the antinociception observed in some studies, it  should be stressed that in 
more than half o f the reported experiments the benzodiazepines had no effect on 
nociception.
1.8.2.1 Mechanism of Action
The antinociceptive effect of benzodiazepines reported by some investigators (Table 1) 
has been attributed to a mechanism involving GAB A, benzodiazepine and opioid 
receptor systems. The increase in ta il-flick latency induced by intrathecal midazolam 
(Goodchild and Serrao, 1987; Edward&et al., 1990) and chlordiazepoxide (Boulter et 
al., 1991) were shown to be effectively antagonised by flumazenil. Similarly, Serrao et 
al., (1989b) reported that flumazenil suppressed the rise in electrical current threshold 
for pain after intrathecal midazolam. Intraperitoneal diazepam also induced a moderate 
increase in ta il-flick latency which was only partially reversed by the benzodiazepine 
antagonist, RO15-3505 (Zambotti et al., 1991). It is suggested that the antinociceptive 
effects of these benzodiazepines stem from their actions at the spinal cord level by 
combination with benzodiazepine receptors (Goodchild and Serrao, 1987; Boulter et 
al., 1991; Zambotti et al., 1991). Supporting the involvement o f the GABAergic 
system in the antinociceptive effect o f benzodiazepine, Kunchandy and Kulkam i,
(1987) found the antinociceptive effect of central type benzodiazepine receptor agonists 
to be bicuculline reversible and to be enhanced by pentobarbitone, a GABAergic 
agent. Furthermore, Kunchandy and Kulkami, (1987) reported that a potentiation of 
benzodiazepine action was seen when clonazepam was combined w ith a sub 
antinociceptive dose o f muscimol, a specific GABAa agonist. Edward et al., (1990) 
found that the analgesic effect of intrathecal midazolam was antagonised by 
intraperitoneal flumazenil and intrathecal bicuculline, a selective GABA antagonist, and 
concluded that the antinociception is mediated by the benzodiazepine GABA receptor 
complex. Evidence for opioid system involvement has been provided by Kunchandy 
and Kulkami, (1987) and Serrao et al., (1989a) who showed that the antinociceptive
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effect of central type benzodiazepine receptor agonists in mouse ta il-flick  and rat tail shock 
assays, was blocked by pretreatment w ith naloxone. In a related study w ith rats, 
Zambotti et al., (1991) showed that diazepam induced increase;v in ta il-flick latency was 
antagonised by MR 2266, a K-opioid antagonist and not by intraperitoneal (5mg/kg) 
naloxone and indicated that a K-opioid receptor mediated mechanism may also be 
involved. However, other reports have shown that naloxone at doses lower than that 
used by Zambotti et al., (1991) produced a complete antagonism of midazolam (Rattan 
et al., 1991) as well as combined midazolam and morphine antinociception (Moreau et 
al.,1988; Yanez et al., 1990; Rattan et al., 1991).
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1.8.3 Effects of Benzodiazepines on Drug-Induced Antinociception
Coadministration of diazepam and other benzodiazepines with opioid drugs is claimed 
to give better pain relief in man (Kanto, 1981; Samuelson et al., 1981; Reves et al.,
1985). Animal studies have shown that the antinociceptive effect o f morphine and 
other agents are modulated by the benzodiazepines (Table 3 ). Surprisingly, the 
majority o f studies have indicated that benzodiazepines cause a decrease in effect o f 
antinociceptive agents, though a few have reported an increase and a small number have 
shown no effect. The reasons for the inconsistency observed in this opioid and 
benzodiazepine interaction is not well understood but has been attributed in part to the 
different testing situations employed by different laboratories (Abbott and Franklin,
1986). For instance, diazepam antagonism of morphine antinociception has not been 
demonstrated in all o f the different types o f nociceptive tests (Rosland et al., 1990) 
many o f which differ in their sensitivity to muscle relaxing effects o f benzodiazepines. 
The nature of stimulus could therefore be critical for such an interaction. I t  has also 
been noted that different species may respond differently to muscle relaxation (Randall 
and Kappel, 1973). However, benzodiazepine induced inh ib ition  o f opioid 
antinociception reported by many (Abbott et al., 1986; Palaoglu and Ayhan, 1986; 
Zambotti et al., 1986; Daghero et al., 1987; Moreau et al., 1988; Rosland et al., 
1990a,b; Rattan et al., 1991) does not correlate with their sedative or muscle relaxing 
properties and separate mechanisms may therefore be involved. For example a 
decrease in fentanyl antinociception by diazepam is not observed at high doses o f 
fentanyl, indicating that the effect of diazepam could be counteracted by increasing the 
opioid dose, thus resembling competitive antagonism (Rosland et al., 1990). This 
observation may agree with an earlier report by Abbott and Franklin, (1986) that low 
doses o f diazepam (Img/kg or less) do not alter morphine antinociception in the tail- 
flic k  test while above 2-Omg/kg, diazepam antagonises morphine antinociception, 
although the mechanism of this antagonism was not established. In the Formalin test, 
Abbott and Franklin, (1986) suggested that diazepam antagonises morphine 
antinociception in a non-competitive manner.
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A few studies have indicated that high doses o f benzodiazepines produce either no 
effect or increase opioid antinociception (Bradshaw et al., 1973; Shannon et al., 1976) 
while others have shown that lower doses produced antagonistic effects (Palaoglu and 
Ahyan, 1986; Daghero et al., 1987; Rosland et al., 1990). In contrast to the latter 
observation. Rattan et al., (1991) reported that in the rat tail flick assay, antinociception 
induced by lower doses ( 10//g  i.t.) o f midazolam and morphine are synergistic but at 
higher doses (20 or 30/<g i.t.), they reduced the extent o f antinociception produced by 
each other.
1.8.3.1 Site and Mechanism of Interaction
The opioids and benzodiazepine antinociceptive interactions appear to be complex and 
have not been clearly elucidated. However, a number of different approaches have 
been taken to investigate the nature o f this interaction. Some investigators have found 
that local injections o f benzodiazepines either into brain stem structures or 
intraventricularly attenuate the effects o f opioids (Zambotti et al., 1986; Mantegazza et 
al., 1982), suggesting that the brain stem structures may be involved in  these 
interactions. Rosland and Hole, (1990b) also indicated that the opioid and 
benzodiazepine interaction takes place along the CNS, possibly in the brain stem, based 
on the finding that mid-thoracic spinalization completely abolished the diazepam- 
induced inh ib ition o f morphine antinociception. The increase in  morphine 
antinociception seen after intrathecal midazolam (Moreau et al., 1988; Yanez et al., 
1990) has also been attributed to the effect midazolam on transmission o f nociceptive 
information at the spinal cord level which is depressed by opioid receptor activation.
Rosland and Hole, (1990b) have shown that diazepam treatment produced no change in 
brain, spinal cord or serum concentrations o f morphine in mice indicating no interaction 
at the pharmacokinetic level. Both opioids and benzodiazepines bind to specific
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receptors in the brain and the finding that synthetic benzodiazepine derivatives bind to
opioid receptors in the brain (Romer et al., 1982) may suggest a possible interaction at
the receptor site. Rosland and Hole, (1990b) however failed to demonstrate any
affin ity o f diazepam or midazolam for pi- orK- opioid receptors in mouse forebrain at
those
concentrations higher than ^  measured in serum after single or repeated injections. 
N-demethyldiazepam, the main metabolite o f diazepam also has no a ffin ity for the pi- 
receptor, suggesting that binding to the opioid receptors is not the mechanism by which 
benzodiazepines inhibit the effect of opioids. In a recent study. Rattan et al., (1991) 
have shown that midazolam had a dual effect on the binding o f opioid ligands to the 
spinal opioid receptors. A t low dose, it potentiated the displacement o f [^H] naloxone 
by morphine but at higher doses midazolam inhibited the binding o f opioid ligands to 
their spinal receptors in the following order o f potency K>à>pi. They concluded that 
the differential antinociceptive effects o f midazolam on morphine-induced 
antinociception involves an interaction with spinal opioid receptors. I t  has also been 
shown that antinociception induced by an opioid like morphine can involve the 
activation o f several neurochemical systems. An example had been reported in the rats 
that were restrained and tested for morphine antinociception using the ta il-flic k  
nociceptive assay. Morphine antinociception was found sensitive to an interaction with 
brain serotonin (5-HT),whose level was elevated by restraint stress (K e lly  and 
Franklin, 1984a). This type of morphine antinociception depends on raphe magnus 5- 
HT fibres projecting to the spinal cord dorsal horn (Basbaum and Field, 1978; Kelly 
and Franklin, 1984b). Other neuronal systems have been implicated in the ta il-flick test 
with unstressed animals (Kelly and Franklin, (1984b) and in the formalin test where 
morphine antinociception does not depend on serotonergic raphe projections to the 
spinal cord (Abbott and Melzack, 1982; Abbott et al., 1982). Benzodiazepines being 
anxiolytic agents may be expected to antagonise the stress potentiated morphine 
antinociception which is dependent on 5-HT fibres. However, the results obtained by 
Abbott and Franklin, (1986) indicated that diazepam antagonism o f morphine 
antinociception was observed only in the formalin test which is insensitive to the
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tryptaminergic mechanism that underlies restraint potentiation o f morphine 
antinociception.
The reports of several studies have linked the mechanism of benzodiazepine modulatory 
effects o f opioid antinociception to a complex interaction involving GABA- 
benzodiazepine receptors as well as the opioid receptor systems. Benzodiazepine 
antagonists are believed to possess no antinociceptive activity over an extensive dose 
range (Tabled) with a few reported exceptions (Walsh et al., 1986; Morgan et al., 
1987a; Kavaliers, 1988). Flumazenil (RO15-1788) has also been shown to have no 
effect on systemically administered morphine (Brady et al., 1984; Kubota et al., 1985) 
but decreases antinociception when morphine is administered centrally (Brady et al.,
1984). Flumazenil has however been shown to reverse the inhibitory action o f 
benzodiazepines against morphine antinociception (Palaoglu et al., 1986; Daghero et 
al.., 1987; Rosland and Hole, 1990b). Others (Zambotti et al., 1986) have reported a 
significant antagonism o f diazepam inhibition o f morphine antinociception using 
specific (R015-1788 and RO15-3505) and non-specific (bicuculline and caffeine) 
benzodiazepine antagonists. These observations suggests that the mechanism o f action 
o f benzodiazepines in reducing morphine antinociception involves an interaction with 
specific benzodiazepine receptors in the central nervous system (Rosland and Hole, 
1990b) and provides additional support to the suggestion that benzodiazepine-receptor- 
mediated mechanisms are involved in the antinociceptive actions of benzodiazepines. 
(Rodgers et al., 1987b; Goodchild and Serrao, 1987; Kunchandy and Kulkami, 1987). 
Other studies have shown that both diazepam-induced increases (Matla et al., 1982) and 
decreases (Palaoglu et al., 1986) o f opioid antinociception are antagonised by 
bicuculline and picrotoxin. The observation that bicuculline, a GABAa  receptor 
antagonist prevented diazepam induced inhibition (Zambotti et al., 1986; Palaoglu et 
al., 1986) and potentiation (Matla et al., 1982) of morphine antinociception point to the 
integral benzodiazepine/GABAA receptor complex being involved in the antinociceptive 
interaction o f benzodiazepines and opioids. Palaoglu and co-workers, (1986) have 
shown further that the chloride channel blocking agent, picrotoxin produced complete
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antagonism of the action of diazepam and potentiated the partial blocking effect o f 
flumazenil against diazepam-induced inhibition of morphine antinociception. Taken 
together, these findings strongly implicate GABAergic system in the antinociceptive 
interactions o f opioids and the benzodiazepines.
Earlier studies had established a link between the antinociceptive action o f morphine 
and GABAergic system but the reports have been contradictory since both antagonistic 
(Ho et al., 1976; Mantegazza et al., 1979; Izumi et al., 1980; Zonta et al., 1981) and 
potentiating (Yoneda et al., 1976; Biggio et al., 1977) effects o f GABAergic agonists 
on opioid antinociception have been shown. Generally however, GABAergic agents 
are believed to produce antinociception in a wide variety of animal test systems and to 
enhance the antinociceptive effect of opioid drugs (For review see Sivam and Ho,
1985). Yanez et al., (1990) have shown that although naloxone had no statistically 
significant effect on intrathecal midazolam antinociception, it  totally reversed the 
antinociceptive effects of midazolam and morphine combination and suggests a 
possibility o f a pharmacodynamic interaction between morphine and midazolam. 
Sim ilarly, Rattan et al., (1991) reported the antinociceptive effect o f combined 
morphine and midazolam to have been prevented by naloxone, an action believed to 
result from the interactions between midazolam and opioid receptors. It is o f interest 
that benzodiazepines and flumazenil reversed the antinociceptive effect o f 
cholecystokinin, an action attributed to the inhibition of cholecystokinin-induced release 
of opioid peptides (Kubota et al., 1985). Cholecystokinin induced naloxone reversible 
antinociception has also been reported in both mice (Zetla, 1980) and rats (Juma and 
Zetla, 1981). Although diazepam reversal of morphine induced antinociception was not 
achieved (Kubota et al., 1985), the association with cholecystokinin may suggest an 
additional mechanism of benzodiazepine interaction with opioid antinociceptive agents.
Benzodiazepine receptors have been demonstrated in the spinal cord (Faull and V illiger, 
1986; Mohler and Okada, 1977), with the highest density o f binding sites occurring 
w ithin laminar II o f the dorsal horn (Faull and V illiger, 1986) a region which plays a
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prominent role in the processing o f nociceptive and thermoreceptive information. The 
benzodiazepines appear essentially to increase the intrinsic efficacy o f GABA at the 
GABAa receptors by increasing the frequency o f chloride ion conductance for a given 
GABA stimulus (Sawynok, 1987). Additionally, the benzodiazepines have been 
shown to modulate morphine antinociception through the supramolecular GABA- 
receptor complex (Palaoglu and Ahyan, 1986). Thus, together with other reports, the 
pharmacological basis fo r the modulation o f opioid antinociception by the 
benzodiazepines, appears to involve GABA benzodiazepine and opioid receptor 
systems.
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1.8.4 Effect of Benzodiazepines on S IÀ
The effects o f benzodiazepines on stress-induced antinociception have been studied 
(Table 5) and the results have not been consistent. Some studies have shown that 
benzodiazepines have no influence on antinociception induced by stress (Rodgers and 
Randall, 1987a; Kavaliers and Innes, 1988; Kavaliers, 1988; Shepherd and Rodgers,
1989). Other studies have shown that benzodiazepines decrease (Rodgers and Randall, 
1987a; Rodgers and Randall, 1987b; Kavaliers, 1988; Kavaliers and Innes, 1988; 
Rovati et al., 1990), and increase (Leitner et al., 1984) stress-induced antinociception. 
The modulatory influence depends upon the type of antinociception (Maier, 1990) 
resulting from the differential application of stress parameters. Both opioid and non- 
opioid mediated forms o f stress-induced antinociception have been shown to be 
modulated by the benzodiazepines. Leitner et al., (1984) reported that diazepam 
treatment (acute or chronic) potentiates antinociception in rats induced by a forced 
3-5min swim in a 2“C water bath, stress parameters which have been shown to activate 
non-opioid antinociception (Bodnar and Sikorszky, 1983). Animals engaged in social 
conflict also activate an intrinsic antinociceptive system the type o f which is dependent 
upon the specific nature o f stimulus situation (Rodgers and Randall, 1987b). 
Prolonged exposure to conspecific attack, which resulted in a long-lasting opioid 
antinociception in intruder mice, is believed to be a passive defence strategy o f 
im m obility (Miczek et al., 1982; Rodgers and Hendrie, 1983; Seigfried et al., 1984; 
Teskey et al., 1984; Rodgers and Randall, 1985; Mickzeck et al., 1986). Animals that 
experience defeat (Rodgers and Randall, 1986a) or a brief exposure to territorial scent- 
marking (Rodgers and Randall 1986b) develop an acute non-opioid form o f pain 
inh ib ition  fo r active defence strategies. It is believed that the two forms o f 
antinociception function to prevent the disruption of ongoing defence (see Rodgers and 
Randall, 1987c for review). Rodgers and Randall, (1987b) reported that diazepam and 
flumazenil induced a dose-dependent blockade o f a non-opioid stress antinociception 
associated with social conflict in mice. Chronic alprazolam pretreatment sim ilarly
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abolishes the non-opioid antinociception normally seen in intruder mice subjected to 
attack from resident conspecifics (Shepherd and Rodgers, 1989).
Non-opioid and opioid distinction between the effects of short and long-term laboratory 
stresses is also evident with a natural, ecologically relevant, stressor. Kavaliers, 
(1988) has shown that a brief (30 seconds and 5 minutes) exposure of w ild male white­
footed mice, Peromyscus leucopus, to a predator (weasel), induces antinociception that 
is blocked by either pre- or post-exposure injections o f diazepam or flumazenil. The 5 
minute exposure and not the briefer (30 seconds) exposure was, in addition, sensitive 
to naloxone antagonism. However, longer exposures (15 minutes) induces a purely 
naloxone and not benzodiazepine reversible antinociception. This suggests that 
prolonged exposure to the weasel leads to an increased activity o f opioid mechanisms 
and a reduction and/or alteration in the expression o f benzodiazepine-related 
mechanisms. The report also confirms other laboratory findings that short-term stress 
produces a non-opioid antinociception while long-term stress produces an opioid 
sensitive antinociception (Amit and Galina, 1986; Bodnar, 1986).
In another study, Kavaliers and Innes, (1988) have shown that exposure to soiled 
home cage bedding of potentially threatening isolated male mice elicited a significant 
increase in nociceptive responses o f male deer mice from mixed sex pairs. This 
antinociception evident after one minute o f exposure, was insensitive to naloxone 
antagonism but was blocked by either pre- or post- olfactory exposure injections o f 
flumazenil or diazepam. However, a fresh bedding treated with the novel odour o f 
peppermint, induced opioid mediated antinociception, being blocked by naloxone and 
not the benzodiazepines. Fresh bedding or the soiled bedding of another mixed sex 
pair had no significant effect on nociception. Rovati et al., (1990) reported that 
clonazepam and diazepam decrease opioid dependent antinociception induced by 
footshock. Benzodiazepine antagonists on the other hand increased the antinociception 
while inverse agonists failed to modify the antinociception. Rovati et al., (1990) also 
found that all the benzodiazepine ligands prevented naloxone reversal o f the footshock 
antinociception. In a series of related experiments (Maier, 1990), antinociception was
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induced in rats subjected to tail-shocks (1,5 and 20) lasting 2-4 minutes that was 
unaffected by prior administration o f diazepam. However, when subjects were allowed 
to remain in the shock environment, a second antinociceptive reaction that was reduced 
or eliminated by prior diazepam administration occurred. This benzodiazepine sensitive 
antinociception was not observed i f  subjects were removed from the shock situation. 
In contrast to these findings, Maier, (1990), has shown that application o f 80 shocks 
were followed by a single antinociception that was sensitive to blockade by diazepam 
throughout its entire course and was not affected by removing subjects from the shock 
environment.
1.8.4.1 Site and Mechanism of Action
Although benzodiazepines were shown to modulate both opioid and non-opioid stress 
antinociception, Maier, (1990) argued that the ability of anxiolytic drug like diazepam to 
reduce or abolish antinociceptive response depends upon whether or not fear and 
anxiety plays a role in precipitating the antinociception. Maier, (1990) believed that the 
in itia l antinociceptive reaction observed after fewer shocks (1,5 and 20), elicited 
antinociception as an unconditional response which was a simple "passive” reaction to 
the physical nature of the shock and is produced at the level of either brain stem, spinal 
cord or both but unrelated to the higher level psychological processes. This 
antinociceptive response is not reduced by the anxiolytic diazepam as it  was not 
precipitated by fear and anxiety. In contrast, the diazepam reversible antinociception 
elicited after 80 shocks (conditioned antinociception) or when the subject remains in the 
shock environment is due to the role of fear and anxiety in the development o f the 
antinociception. Earlier studies Fanselow and Helmstetter, (1988) have indicated that 
midazolam, chlordiazepoxide and diazepam were all capable of significantly attenuating 
antinociception associated with conditioned footshock. In addition, midazolam and 
diazepam also reduced freezing responses, an index of fear induced by the footshock 
(Bouton and Bolles, 1980). The benzodiazepines action on these responses is said to
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result from their anxiolytic property since they failed to produce increases in 
responsiveness to painful stimuli in situations not associated w ith the footshock. 
Fanselow and Helmstetter, (1988) believed that although the three drugs had some 
effect on motor activity levels, it is unlikely that their ability to reduce freezing and 
antinociception was produced by a motor impairment
Explaining the possible role of anxiety in the development o f stress-induced 
antinociception, Rovati et al., (1990), suggested that the decrease in opioid dependent 
footshock antinociception by clonazepam and diazepam could be attributable to a 
possible synergistic effect with an endogenous benzodiazepine receptor agonist whose 
activation by stress is predictable. They suggested that exogenous agonists like 
diazepam and clonazepam may act synergistically with the endogenous agonist to block 
the development o f antinociception induced by footshock. Rovati et al., (1990) 
however demonstrated that anxiety does not play a pivotal role in stress-induced 
antinociception since inverse agonists that are by themselves anxiogenic (Prado de 
Caralho et al., 1983) had no effect on the antinociception. Since the benzodiazepines 
have many other actions, Maier, (1990) suggests that benzodiazepines might reduce 
stress-induced antinociception for reasons other than their anxiolytic property. Some 
investigators (Kavaliers and Innes, 1988; Rodgers and Randall, 1988) believe that the 
modulation o f stress induced antinociception by benzodiazepines is associated w ith 
alterations in the activity and/or modulation of benzodiazepine systems. I t  has been 
speculated that the benzodiazepine-gamma amino butyric acid (GABA) receptor 
chloride ion complex is under both tonic and acute regulation by the environment and 
may subserve a physiologically and behaviourally relevant function in mediating 
responses to stressful or anxiety producing situations (Trullas et al., 1987).
Zarrindast and Sabetkasai, (1992) investigated the effects o f GABAergic agents in the 
presence or absence o f swim-stress in mice and reported that although stimulation o f 
both GABAa  and GABAp receptor sites has antinociceptive effect, the involvement o f 
a GABAergic mechanism in stress-induced antinociception is unlikely. This is because
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phaclofen, a GABAb receptor antagonist^ decreased the antinociceptive response 
induced by baclofen (GABAb receptor agonist) and swim-SIA but not by SIA alone. 
Sim ilarly, bicuculline or picrotoxin, GABAa  receptor antagonists, reduced the high 
level o f antinociception induced by a combination o f muscimol (G ABAa  receptor 
agonist) and SIA but these two antagonists failed to reduce SIA alone. This suggests that 
both GABAa  and GABAb receptor agonists enhanced SIA by mechanisms other 
than activation of GABAa  and GABAb receptors respectively. However in a related 
study, Tokuyama e t a l v ,  (1992) have shown^that GABAergic systems play an 
important role in the production o f different stress-induced antinociception including 
psychological, footshock and swim stress and that the participation o f GABA receptor 
subtypes in SIA was different for each o f the stressors investigated.
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1.8.5 Concluding Remarks
The modulatory roles o f benzodiazepines in the development o f nociceptive and 
antinociceptive responses is not conclusive. On their reaction to nociceptive stimuli, a 
vast number o f experimental findings indicate that benzodiazepines are not 
antinociception per se since they were shown to have no effect and in some instances 
induced a decrease in response (nociceptive) latency. However, in some studies they 
induced increases in nociceptive responses, an action believed by some investigators to 
be associated with their sedative-hypnotic actions which clearly inhibit motor functions. 
Therefore in assessing the effects o f benzodiazepines on nociceptive stim uli, their 
sedative-hypnotic actions should not be ignored as a possible factor responsible fo r the 
‘ apparent antinociception’ . In spite of the controversy on their antinociceptive efficacy, 
it is o f interest to note that increases in response latency have been observed following 
benzodiazepines administration via some routes and not others. Reasons for the 
different findings w ith respect to routes w ill need to be investigated further. 
Benzodiazepines*induced effects on opioid antinociception clearly point to their having 
a modulatory role via an interaction with pain mediating pathways in the central nervous 
system. The molecular mechanism/s underlying this interaction is, however, far from 
clear but the evidence so far, points to a mechanism believed to involve the 
contributions o f GABA, benzodiazepines and opioid receptor systems. Like the opioid 
antinociception, benzodiazepines effects on SIA have also not been conclusive. Both 
opioid and non-opioid forms of stress antinociception have reportedly been modulated 
by the benzodiazepines. Some investigators believed that their modulatory role on SIA 
depends upon the involvement o f fear and or anxiety in  precipitating the 
antinociception, however, in view o f other pharmacological action o f the 
benzodiazepines such as sedative and hypnotic effects, SIA modulation fo r reasons 
other than their anxiolytic property have not entirely been ruled out. I t  has been 
suggested that interactions of GABA-benzodiazepine system with the opioid and non-
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opioid pain inhibitory systems may in part also account for the benzodiazepines actions 
on SIA.
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CHAPTER TWO
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CHAPTER TWO
2 ONTOGENESIS OF SIA IN NEONATE RAT
2.1 Introduction
Studies o f opioid physiology and pharmacology indicate that the neonatal period is 
characterised by a substantial and also differential ontogenetic profile of opioid peptides 
and receptors. The degree to which these patterns o f opioid development are reflected 
in the ontogeny of behavioural functions remain to be fu lly  elucidated. For instance, 
studies on the developmental changes in antinociception known to be mediated by 
opioids have yielded conflicting reports. Blass et al., (1993) have shown that 
morphine mediated antinociception is observed in neonate rats as early as day 2 , in the 
hot plate test. Antinociception induced by k  opioids (ethylketocyclazocine and 
bremazocine) have also been reported in 2 day old rats by Helmstetter et al., (1988). In 
contrast to thèse findings, Giordano and Barr, (1987) failed to observe either moiphine 
or ketocyclazocine induced antinociception in 3 day old rats as assessed by tail or hind 
paw retraction from a hot water bath.
Studies have shown that endogenous antinociceptive systems such as SIA also evolve 
differentia lly as a function o f age and depend upon the ontogenesis o f the 
antinociceptive response (i.e. hormonal or non hormonal) involved. Swim SIA has 
been observed in young (2 0  days old) rats and the neurochemistry and receptor control 
o f this response differs at this preweanling age in comparison with the adult (Jackson 
and Kitchen, 1989a; Kitchen and Pinker, 1990). Because swimming behaviour in the 
rat does not properly develop until days 12-15 (Schapiro et al., 1970; Salas 1972), it  
has proven d ifficu lt to study swim SIA in preweanling animals. Further, in contrast to 
swim stress, other stressors, such as electroshock and cold exposure, are more severe 
and for ethical reasons are thus less desirable. In this study, an attempt was made to
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develop a methodology for using warm-water swimming stress in rat pups to enable the 
study o f swim-SIA down to the age o f 2 days without distress to the animals and for 
characterisation o f the ontogeny of the opioid form of swim SIA.
2.2 METHODOLOGY
2.2.1 Animals and Experimental Conditions
Wistar albino rats ( University o f Surrey strain ) o f mixed sexes were used in  all 
experiments. Throughout the study animals were maintained at a constant temperature 
o f 22°C, humidity of 45-55% and on a 12 hour light dark cycle (lights on at 7.00 hrs, 
o ff at 19.00 hrs). Spratts expanded laboratory diet No 1 was fed adlibitum. Two 
virgin female rats (180-250g) were caged with one male rat from Monday to Friday. 
Conception was determined by the presence o f sperm in vaginal smear obtained by 
introducing 0.1ml o f 0.9% Wy saline into the vagina and then withdrawing and 
examining under a phase contrast light microscope (magnification xlO). Females w ith 
a positive smear were transferred to individual breeding cages.
Close to parturition (at 21 days after conception) females were checked daily fo r 
littering. Litters bom on the same day were randomly cross fostered. Eight pups were 
randomly assigned to each dam. Any litte r with less than 6  pups or which 
subsequently fe ll to less than 6  pups due to neonatal mortality were removed from the 
study. A ll litters were weaned at day 21 and the process involves separating the mother 
permanently from the pups.
On the morning of testing, the pups were weighed individually and marked, the weight 
being used to calculate appropriate doses o f the opioid antagonist, naloxone. The 
experimental laboratory was windowless, air controlled and maintained under the same 
conditions as the animal house with a constant temperature o f 22“C humidity o f 45- 
55% and a 12 hour light dark cycle (lights on at 7.00 hrs, o ff at 19.00 hrs). The 
laboratory was maintained at a minimal noise level. Test litters were introduced into the
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laboratory at least 24 hrs prior to testing to equilibrate and all experimental procedures 
carried out after equilibration.
2.2.2 Swimming Aid Devices and Swim Stress Procedures
For the induction of stress-induced antinociception, neonatal rats o f both sexes from the 
dam were swum individually in a plastic tank (29x22x28cm deep) containing water at 
20°C ± r c  fo r a period o f 3min as previously described for 20 day old animals 
(Jackson and Kitchen, 1989a). This procedure proved successful for 15,20 and 25 day 
old rats. However, 10 day old rats exhibited swimming behaviour for less than Im in 
and were unable to continue to float. To study swim SIA in animals 10 days and less 
floatation devices consisting o f rings of polystyrene (akin to the rubber ring used for 
children) were in itia lly  assessed. These proved unsatisfactory as they prevented 
freedom of movement causing the pups to struggle and within one min the rat became 
immobile. The alternative approach which proved successful was to attach a harness to 
the trunk o f the pups attached by a hook and a single string to a horizontal bar 
connected to a retort stand placed centrally over the swimming tank. 5mm plastic cable 
ties w ith self locking fasteners (R.S.Components, London) were used fo r the harness 
device which allowed infinite adjustment from 1cm to 3.5cm diameter. The harness 
was adjusted so that both front and hind paws were free but without any pressure being 
exerted on the thorax or abdomen. The degree of immersion of the animals could be 
finely adjusted using a rack and pinion adjuster on the stand. Neonatal rats were 
immersed sufficiently to induce a paddling type of response and the harness allowed 
appreciable movement around the swimming tank whilst maintaining a fixed ventral 
posture. A t the end o f the swimming period, rats were removed from the harness by 
cutting the cable ties with scissors, dried and returned to the home cage before 
subsequent nociceptive testing.
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2.2.3 Nociceptive Testing
The antinociceptive effect o f swim stress was measured using the tail immersion test 
(Janssen et al., 1963) with some modifications fo r use in neonates (Kitchen et al., 
1984). A ll testing was carried out between ll.OOhrs and 16.00hrs to minimise diurnal 
variation in nociceptive response. Tail immersion procedures were carried out by 
holding the pup upright in the hand and immersing the terminal 2cm (2 and 5 day old 
rats), 3cm (10 day old rats) or 5cm (15, 20 and 25 day old rats) o f the tail in a water 
bath maintained at 43.5°C (2 and 5 day old rats), 47.5°C (10 day old rats) and 50°C 
(15,20 and 25 day old rats) as previously described for use in neonates (Kitchen et al., 
1984; De Cabo et al., 1992). The choice o f temperatures ( found appropriate fo r 
measurements o f nociceptive reaction time ) were based on previous studies (De Cabo 
et al., 1992) which have shown that at ages below 10 days, deviation o f ± 0.5°C from 
43.5°C produces either instant removal o f the tail or absence o f response. Use of 
47.5°C at day 10 and 50°C at later ages was aimed at producing an equivalent basal 
response time (De Cabo et al., 1992) since in animals older than 10 days o f age, 
consistent nociceptive responses are not achievable at the lower temperature, 43.5“C 
(De Cabo et al., 1992). Nociceptive reaction times were determined with a hand held 
stop-watch and were taken as the point when the tip o f the tail was withdrawn from the 
surface o f the water. A maximum cut-off time o f 10 seconds was employed to prevent 
tissue damage.
Animals were divided into stressed and unstressed groups and were treated with either 
saline or naloxone (1 or lOmg/kg). Nociceptive reaction times were measured 
immediately before intraperitoneal (i.p.) injection of saline or the opioid antagonist, 
naloxone, lOmin before a 3min period o f swimming stress and at 1, 5, 10, 15 and 30 
min following swim stress, for both unstressed and swim-stressed animals. Measures 
o f nociception (n>6 ) represents estimates from at least three litters carried out on at least 
three separate days. This protocol minimises interday and interlitter variation in 
nociceptive responses. For all experiments performed with litters up to the age o f 20
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days, pups remained with the mother except during drug administration, swim stress 
or nociceptive testing only, to minimise stress to the pups due to maternal deprivation.
2.2.4 Drugs and Statistical Analysis
Naloxone was obtained from Dupont. Drug solutions were made in  0.9% saline. 
Antinociception induced by a 3min swimming stress and its antagonism by naloxone 
was analysed at each time point by a one-way analysis o f variance and post-hoc 
comparisons with Duncans New Multiple Range Test using the SuperANOVA package 
for the Macintosh.
2 .3  RESULTS
In confirmation o f the work of Schapiro et al., (1970) 15 day old animals were able to 
swim properly, unaided. In this study ten day old and younger neonates encountered 
swimming d ifficu lty. The swimming harness employed enabled 3min periods o f 
swimming to be observed in 2, 5 and 10 day old rats without distress. Figures 3(a-f) 
shows the ontogenetic profile of swim-stress induced antinociception from day 2  to day 
25. There was no indication o f antinociception in 2 or 5 day old rats after swimming 
stress (figs.3a and b). A t day 10 (fig.3c) however, swimming produced a small but 
significant increase in tail immersion latency 5 min after swim stress an effect which 
was completely reversed by naloxone (lOmg/kg). A t day 15 (fig.3d) the level o f SIA 
was greater and also significantly attenuated by the opioid antagonist. A t this age a 
greater level o f SIA could be achieved (5min response latency; 6.59 ±  0.5) i f  the 
immersion temperature was reduced to 47.5°C (fig.4). Naloxone (lOmg/kg) 
completely antagonised SIA using these parameters (5min response latency; 3.05 ±  
0.55). A level o f SIA approaching that observed in the adult (Kitchen and Pinker,
1990) was observed in 20 (fig.3e) and 25 (fig.3f) day old rats and was also sensitive to
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naloxone (lOmg/kg) reversal. However, no significant attenuation o f the SIA was 
achieved in 25 day old rats with Img/kg naloxone (fig.5).
85
Figure 3. Effect of 3 min. swimming stress on nociceptive response in 
(a) 2-, (b) 5-, (c) 10-, (d) 15-, (e) 20-, and (f) 25- day old rats. Values represent 
mean, and vertical bars, s.e. mean for groups of six animals. (O) Saline 
injected, unstressed. (# ) Saline injected, swim-stressed. (□ ) Naloxone 
lOmg/kg, unstressed. (■ ) Naloxone lOmg/kg, swim-stressed. Tail immersion
temperatures,43.5^C for (2 and 5 day), 47.5°C for (10 day) and 50^C for (15, 
20 and 25 day) old rats. Treatment groups were compared using ANOVA and 
post hoc comparisons made by Duncans New Multiple Range Test. *p< 0.05 
swim-stressed versus appropriate unstressed control. +p < 0.05 naloxone 
treated, versus saline-treated swim-stressed.
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Figure 4. Effect of 3 min. swimming stress on 
nociceptive response in 15- day old rats. Values 
represent means, and vertical bars, s.e. mean for 
groups of six animals. (O) Saline injected, 
unstressed. (# ) Saline injected, swim-stressed. (□ ) 
Naloxone lOmg/kg, unstressed. (■) Naloxone 
lOmg/kg, swim-stressed. Tail immersion
temperature, 47.5%. Treatment groups were 
compared using ANOVA and post hoc comparisons 
made by Duncans New Multiple Range Test. 
*p<0.05 swim-stressed versus appropriate unstressed 
control. +p< 0.05 naloxone treated, versus saline- 
treated swim-stressed.
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Figure 5. Effect of 3min. swimming stress on 
nociceptive response in 25-day old rats. Values 
represent means, and vertical bars, s.e. mean for groups 
of six animals. (O) Saline injected, unstressed. (# ) 
Saline injected, swim-stressed. (□) Naloxone Img/kg, 
unstressed. (■ ) Naloxone Img/kg, swim-stressed. Tail
immersion temperature, 50^C. Treatment groups were 
compared using ANOVA and post hoc comparisons 
made by Duncans New Multiple Range Test. *p< 0.05 
swim-stressed versus appropriate unstressed control.
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2.4 D ISCU SSIO N
Stress-induced antinociception (SIA) is an adaptive physiological response which can 
be induced by a number o f different stressors as described in section 1.3. Swim-SIA 
has been used extensively to study the nature o f intrinsic pain suppressive 
mechanisms. This form of SIA has been particularly useful as by varying the duration 
or temperature o f swimming, it is possible to dissociate opioid and non-opioid forms of 
the behaviour, on the basis of naloxone reversal or naloxone insensitivity, respectively. 
Swim-SIA studies at ages lower than 10 days in the rats have not been reported 
previously and may be due to lack o f swimming behaviour at these young ages. 
Swimming behaviour is known to develop properly between 12-15 days o f age 
(Schapiro et al., 1970; Sallas, 1972). Using the swimming harness described in 
section 2.2.2, it  has proved possible to observe swim SIA as early as day 10, an age 
when unaided swimming is only possible for short periods (less than Im in). Swim- 
SIA at this age is sensitive to reversal by naloxone which clearly points to opioid 
receptor mediation and provides a contrasting development to the non-opioid form of 
swim SIA which is not evident until postnatal day 25 (Jackson and Kitchen, 1989a). 
In  2 and 5 day old rats, the lack o f SIA may be related to immaturity o f the 
hypothalamus-pituitary-adrenal system as short swim SIA is hormone dependent 
(Jackson and Kitchen, 1989a) and the hypothalamus-pituitary-adrenal axis does not 
become truly functional until the second postnatal week in the rat (Henning, 1978; 
Walker et al., 1986). During the first two weeks of life, neonatal rats show a period of 
diminished adrenocorticotrophic responsiveness to stress (Bailey and Kitchen, 1987; 
Angelogianni and Gianoulakis, 1989) and have reportedly exhibited a reduced capacity 
to secrete p-endorphin like peptides (P-gLPs) in response to stress (Angelogianni and 
Gianoulakis, 1989). The lack o f SIA is unlikely to reflect underdeveloped opioid 
systems as in young rats /«-opioid receptors operate SIA (Jackson and Kitchen, 1989a) 
and /«-mediated behaviours can be clearly demonstrated in 2-5 day old pups (Pasternak 
et al., 1980; Zhong-Zhang and Pasternak, 1981; Jackson and Kitchen, 1989b). 
Further in response to social or sexual isolation short lasting antinociception is
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observed in 14 day old animals and not in 7 day old rats again pointing to a lack o f 
stress-mediated pain suppression until the second postnatal week (Takahashi et al.,
1991).
The observation that in 15 day old rats, a greater level o f SIA was achieved when the 
immersion temperature was reduced from 500C to 47.50C agrees well w ith previous 
studies (De Cabo et al., 1992) which shows that the choice o f ta il immersion 
temperature is critical for the production o f equivalent basal response time in  
experiments involving animals of different ages. The age related increase in the level of 
SIA responses observed between 10-25 day old rats is suggestive o f the level o f pain 
tolerance which correlates with the ontogenesis of the pain suppressive mechanisms. 
Studies have shown that the neurochemistry involved (essentially the opioid systems) 
are immature at birth and reach mature levels after an extended period o f development 
(Pasternak et al., 1980; Zhong-Zhang and Pasternak, 1981; Jackson and Kitchen, 
1989b). The possibility that the observed SIA may not reflect a reduced pain 
perception alone and could be secondary to alterations in , fo r example 
thermoregulation, has been addressed. Previous studies in our laboratory (Jackson and 
Kitchen, 1989a) and in others (Bodnar et al., 1978d; Bodnar and Sikoszky, 1983; 
Terman et al., 1986) have dissociated the hypothermic and antinociceptive effects o f 
swim stress by showing that the hypothermia was unaffected by naloxone antagonism. 
Reversal of swim-SIA by naloxone in 15-25 day old rats sim ilarly points to opioid 
receptor mediation. The failure to significantly antagonise SIA in 25 day old rats using 
Img/kg naloxone is not surprising. It should be expected that a higher dose w ill be 
more effective in antagonising the SIA than a lower dose and dose dependent 
reductions by naloxone of antinociception induced by cold water stress have been 
reported (Bodnar et al., 1978e).
In conclusion it  has been shown using a swimming aid device that short warm water 
swims can induce SIA as early as postnatal day 10 and that this response is opioid 
receptor mediated and develops rapidly up to the age of weamng.
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CHAPTER THREE
3 PERINATAL EFFECTS OF DIAZEPAM ON OPIOID FUNCTION
3.1 Introduction
The opioid peptide system in the brain is probably the most extensive and diverse 
peptidergic transmission system which has control over several physiological functions 
including pain, locomotion, mood, diuresis, thermoregulation, stress, respiratory, 
gastrointestinal and cardiovascular function. A number o f associations between the 
pharmacological effects o f benzodiazepines and opioids have been made at the clinical, 
physiological and molecular level. Many reported studies have indicated that chronic 
exposure of benzodiazepines to animals is associated with a significant behavioural and 
biochemical alterations that could affect the offspring some o f which may persist for 
years or into adulthood (Frieder and Grimm, 1985; Ryan and Pappas, 1986; Cagiano et 
al., 1990). Su and Yu, (1986) have indicated that maternal diazepam exposure may 
inhibit early brain development in the offspring and cautioned their use w ith care in 
pregnancy. Livezey et al., (1985). have also shown that perinatal exposure o f rats to 
diazepam has an enduring and detrimental effect on their ontogenesis and sleep 
mechanisms.
O f the variety o f peptides known to be localised within the central nervous system, the 
endogenous opioid peptides have become a particularly attractive candidates for 
investigation w ith regard to their inter-relationships w ith the benzodiazepine 
tranquillisers. One area o f interest that has in the recent years received attention, is the 
effect o f the benzodiazepines and their antagonists on nociceptive and antinociceptive 
(drug and stress-induced) responses especially that involving the opioid system (See 
section 1.8). The majority of the studies referenced in  the tables 2,3,4 and 5
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investigated the effects o f benzodiazepines on pain responses upon acute 
administration. L ittle  is known on the effect o f chronic (long-term) administration of 
the benzodiazepines upon neonatal control o f stress responses such as SIA. Since the 
therapeutic use of benzodiazepines for their anxiolytic and hypnotic actions is extremely 
widespread and indeed chronic abuse o f these tranquillisers is prevalent in some 
populations throughout the world (Marks, 1985; Senay, 1989), this study addresses 
the issue o f how maternal exposure to benzodiazepines peiinatally might influence the 
development of opioid systems. Specifically, the effect of maternal diazepam exposure 
on the development o f opioid control o f stress-induced antinociception in the offspring 
is investigated. Measurement o f serum corticosterone levels o f diazepam and 
determination o f //-opioid receptor binding in 2 0  day old neonates was also carried out 
with a view to determination o f the possible mechanism of effect of diazepam on opioid 
systems. Furthermore, measurement o f flu id  intake and weight gain was undertaken 
and is intended to assess the effect on growth and development of the offspring. Thé 
|chemical structure of diazepam is shown in figure 5.
Figure 6  Chemical Structure o f Diazepam
CH3
a =  N
,Q
DIAZEPAM
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3.2 METHODOLOGY
3.2.1 Animals and Experimental Conditions
The housing conditions were as previously described in Section 2.2.1. Females with a 
positive smear were transferred to individual breeding cages and assigned to one o f the 
four treatment groups:-
a) Control uninjected group
b) Vehicle (for diazepam) injected group
c) Diazepam ( lOmg/kg) injected group
d) Diazepam (Img/kg) injected group
Female weight gain and flu id consumption were recorded thrice weekly. Litters bom 
on the same day were randomly cross fostered within the same treatment group. Dams 
and litters were weighed, counted and fluid consumption recorded thrice weekly as was 
done prenatally with the mother until the experimental day. Litters were weaned 
sim ilarly at day 21. On the day of weaning pups were counted and weighed, flu id  
consumption measured and the dam after weighing was removed from the litter. A ll 
litters were subsequently maintained on tap water and fluid consumption recorded until 
the day o f experiment.
3.2.2 Chronic Diazepam Treatment
Diazepam (Roche Products Ltd., UK.) was dissolved in a vehicle which was made up 
o f 64% w/y polyethylene glycol 16% ^/y Ethanol and water. Diazepam (lOmg/ml and 
1 mg/ml) was first dispersed in polyethylene glycol followed by the addition o f ethyl 
alcohol and the required volume was made up with distilled water. Daily subcutaneous 
(s.e.) injections o f diazepam lOmg/kg, Img/kg as well as the vehicle (equivalent 
volume) were made to dams of the respective groups according to body weight from
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gestation day 1 (sperm ■ positive day) to the postnatal day of experiment or weaning 
(day 21) for animals tested at day 25. Naloxone solution was prepared by dissolving 
the required quantity in 0.9% saline. In all the treatment groups, 10,15,20 and 25 day 
old neonates were used for the study.
3.2.3 Swim Stress Procedures and Nociceptive Testing
Swim stress procedures and nociceptive testing were carried out as previously 
described in section 2.2.2 and 2.2.3. Swim-SIA and its reversal by the opioid receptor 
antagonist, naloxone, was assessed in rat pups from vehicle and diazepam-treated 
mothers at postnatal day 10, 15, 20 and 25. Naloxone solutions were prepared by
dissolving the required quantity in 0.9% saline. Separate groups o f vehicle and
(
diazepam-treated animals were assessed at each age and include both male and female 
neonates bom in each litter.
3.2.4 Corticosterone Estimation
fluorimetrically
Plasma corticosterone was assayed i : I  v y in 20 day old neonates o f perinatal 
diazepam and vehicle treated mothers by a modification (Kitchen and Rowan, 1984) of 
the method of Zenker and Bernstein, (1958). In both the diazepam and vehicle treated 
groups, saline injected stress and unstressed as well as naloxone injected stress and 
unstressed rats were used for the assay. Trunk blood was collected into heparinised 
tubes and plasma was separated by centrifugation at 4000g for lOmin at 4 C (Beckman 
J6  centrifuge). Img/ml corticosterone in ethanol was diluted with saline to produce a 
standard curve from 0.01-0. l//g/m l. lOOjA o f plasma was diluted to 1ml w ith distilled 
water and 1ml of standard solutions were used for assay. Samples were vortexed w ith 
1 0ml chloroform for 1 0  seconds. 8 ml of the chloroform layer was then withdrawn and 
mixed w ith 3ml o f ethanol/concentrated sulphuric acid mixture (3:7 by volume) and
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vortexed for 5 seconds. Fluorescence was measured in the ethanol/acid layer after 
90min using a spectrofluorimeter (Perkin Elmer LS-5 Luminescence Spectrometer) set 
at an excitation wavelength of 475nm and an emission wavelength o f 525nm, slit width 
o f 5  and an integrated measurement made over 8  seconds.
3.2.5 Receptor Binding Studies
3.2.5.1 Membrane I Preparation
Brains were dissected on ice according to the method o f Glowinski and Iversen, 
(1966). Animal were decapitated and whole brain was removed and dissected over an 
ice tray into six different regions : cortex, striatum, medulla, midbrain, hypothalamus 
and hippocampus. Tissue samples were homogenised in incubation buffer (50mM) 
Tris-HCl, pH 6 .8  at 0“C with a polytron homogeniser at setting 6  for 15 seconds. The 
homogenate was made up to l(X)ml vol. with buffer and centrifuged at 25,(XX)g for 
15min (Beckman Ultracentrifuge L5-65B, rotor 45Ti). The supernatant was discarded 
and the pellet re suspended in l(X)ml vol o f ice cold 50mM Tris HCl pH 7.7 at 37°C. 
This suspension was incubated in a shaking waterb.ôth at 37°C for 45min fo r the 
removal o f endogenous opioids. A fter this pre-incubation, the suspension was 
recentrifuged at 25,000g for 15min. The supernatant was discarded and the resultant 
pellet resuspended in a small volume of ice cold 50mM Tris-HCl pH 7.5 at 25°C and 
homogenised for 15 seconds. The final homogenate was made up to required volume 
o f lOmg/ml and used for all receptor binding assays.
3.2.5.2 Binding Assay
For all brain regions, single point assays were conducted using a Kd concentration o f 
l.OnM [^H] DAGO established in previous studies in our laboratory (Yeadon and
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Kitchen, 1988). A ll assays were conducted in triplicate using a final incubation volume 
o f 2ml containing 19mg (lOmg/ml) o f brain tissue. Ligand dilutions and additions 
were made with ice cold 50mM Tris HCl buffer pH 7.5 at 25°C. Incubations were 
carried out in a shaking water at 25°C for 45min in the presence or absence o f 
displacing ligand (naloxone, 1//M) to determine non-specific binding. Incubation was 
terminated by rapid filtration under vacuum through whatman GF/B filte r papers pre­
soaked in buffer. The filters were washed in triplicate with 5ml of ice cold 50mM Tris 
HCl buffer pH 6 .8  to remove any free ligand. The filte r disk was then transferred to a 
5ml scintillation vial and 0.5ml o f a 20%v/v Triton X -100 in toluene solution w ith 
4.5ml o f unisolve E scintillation flu id  was added. Tubes were capped and le ft 
overnight before liquid scintillation counting.
Efficiency o f counting was determined in triplicate using 10ml aliquots o f [^H ] n- 
hexadecane standard both on its own and with homogenate coated filte r and Triton X- 
100 solution. Specific binding o f [^H] DAGO was defined as the difference in binding 
in the absence and presence of 1//M naloxone.
3.2.6 Statistical Analysis
Statistical comparisons within each series o f treatments were made using one-way 
ANOVA and post hoc comparisons with Duncans New Multiple Range Test using the 
SuperANOVA package for the Macintosh.
3.3 RESULTS
3.3.1 Effect of Diazepam on Maternal and Neonatal Weight
Figures 7-10 shows the effect of chronic diazepam treatment on maternal and neonate 
weight gain during gestation and the postnatal period up to the
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maximum age of testing (day 25). There were no significant effects o f diazepam 
treatment upon maternal weight gain or upon litter weight in all groups over a chronic 
treatment period up to postnatal day 25.
3.3.2 Effect of Diazepam on Fluid Intake
Chronic maternal diazepam intake had significant effects on fluid consumption (Figs 11 
and 12). Diazepam treatment increased fluid intake by up to 40% compared to controls, 
an effect which was most marked in the pre- (Figs 11a and 12b) and early postnatal 
(Figs 1 la  and b) periods and in part was due to increased flu id consumption due to 
vehicle treatment. Significant differences (up to 40%) between diazepam and vehicle 
treated groups were also observed but only in the measures o f flu id  intake fo r the 
prenatal period (Fig 12b).
3.3.3 Effect of Diazepam on SIA Ontogenesis in Neonate Rats
A small level o f swim-stress induced antinociception (peak response latency 2.4-2.7s 
vs 1.2-1.6s) was observed in vehicle (Fig 13a) and both diazepam-treated groups (Figs 
13b and c) in 10 day old rat pups. In 15 day old animals swimming stress produced a 
more marked antinociception in vehicle (Fig 14a) and diazepam treated groups (Figs 
14b and c). In rats treated with lOmg/kg diazepam (Fig 14c) there was more variability 
in the nociceptive latencies and the antinociception did not reach statistical significance. 
Naloxone produced some attenuation o f the swim-stress induced antinociception but 
this was not significant in any groups.
In 20 day old preweanling rats a significant level o f swim-stress induced 
antinociception which was completely reversed by naloxone was evident in vehicle 
treated rats (Fig 15a). In diazepam treated animals (1 and lOmg/kg) there was stress-
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induced antinociception but this was insensitive to reversal by naloxone (Figs 15b and
c). In  25 day old (postweanling) rats, again marked swim-stress induced 
antinociception, reversed by naloxone, was observed in vehicle treated rats (Fig 16a) 
but the increase in response latencies observed in animals treated with Img/kg diazepam 
were not affected by the opioid antagonist. (Fig 16b). Further in  animals treated w ith 
diazepam lOmg/kg swim stress did not produce any significant antinociception (Fig 
16c).
3.3.4 Effect of Diazepam on I^Hl DAGO Binding
Fig 17 represents pH ] DAGO binding (B max) in 20 day old diazepam (lOmg/kg) and 
vehicle treated rats. Binding was determined in six different brain regions; cortex , 
medulla, striatum, midbrain, hypothalamus and hippocampus. There were no 
significant differences between the diazepam and vehicle treated groups in all the 
regions studied. However, diazepam treated rats show lower specific binding in the 
cortex, medulla and the midbrain and a higher specific binding in striatum, 
hypothalamus and hippocampus respectively compared to the vehicle treated groups.
3.3.5 Effect of Diazepam on Plasma Corticosterone
Plasma corticosterone levels were measured in 20 day old neonate rats. Diazepam 
(lOmg/kg) treated animals were compared with the vehicle treated in four test groups; 
saline stressed/unstressed and naloxone stressed/unstressed (fig 18). Chronic maternal 
diazepam treatment had no significant effect on corticosterone levels in  a ll the test 
groups compared with the vehicle control.
100
400 
350 
300 
®  250 
%
7 S 200 
£
k 150 
^  100 
50 
0
Conception Litter day 1 Test day
^ 200
k 150
Conception Litter day 1 Test day
Figure 7. Maternal body weight at conception, after birth and at the postnatal testing 
day. Histograms represent mean and vertical bars, s.e. mean for the control untreated 
(unfilled), vehicle treated (dotted), diazepam lmg/&g (stripes) and diazepam lOmg/kg 
(filled) treated groups at (a) 10 and (b) 15 days o f age. Values are the means o f 3-4 
mothers for each treatment group. Statistical comparisons w ithin each series of 
treatments were made using one-way ANOVA and post hoc comparisons using 
Duncans New Multiple Range Test. No significant differences observed.
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Figure 8 . Maternal body weight at conception, after birth and at the postnatal testing 
day. Histograms represent mean and vertical bars, s.e. mean for the control untreated 
(unfilled), vehicle treated (dotted), diazepam 1 mg/kg (stripes) and diazepam lOmg/kg 
(filled) treated groups at (a) 20 and (b) 25 days of age. Values are the means o f 3-4 
mothers for each treatment group. Statistical comparisons within each series of 
treatments were made using one-way ANOVA and post hoc comparisons using Duncans 
New Multiple Range Test *p<0.05 vs Control untreated group +p<0.05 vs Vehicle 
injected group.
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Figure 9. Neonate body weight at birth and at the postnatal testing day. 
Histograms represent mean and vertical bars, s.e. mean for the control 
untreated (unfilled), vehicle treated (dotted), diazepam Img/kg (stripes) 
and diazepam lOmg/kg (filled) treated groups at (a) 10 and (b) 15 days 
o f age. Values represents the mean litter weight divided by pup number 
o f 3-4 litters for each treatment group. Statistical comparisons within 
each series of treatments were made using one-way ANOVA and post 
hoc comparisons using Duncans New Multiple Range Test . No 
significant differences observed.
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Figure 10. Neonate body weight at birth and at the postnatal testing 
day. Histograms represent mean and vertical bars, s.e. mean for the 
control untreated (unfilled), vehicle treated (dotted), diazepam Img/kg 
(stripes) and diazepam lOmg/kg (filled) treated ^oups at (a) 20 and (b) 
25 days o f age. Values represents the mean htter weight divided by 
pup number o f 3-4 litters for each treatment group. Statistical 
comparisons within each series of treatments were made using one-way 
ANOVA and post hoc comparisons using Duncans New M ultiple 
Range Test. No significant differences observed.
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Figure 11. Total flu id consumption from conception to birth (prenatally) 
and from birth to the testing day (postnatally). Histograms represent mean 
and vertical bars, s.e. mean for the control untreated (unfilled), vehicle 
treated (dotted), diazepam Img/kg treated (stripes) and diazepam lOmg/kg 
treated (filled) ^oups at (a) 10 and (b) 15 days o f age. Values are the 
means o f 3-4 litters for each treatment group. Statistical comparisons 
within each series of treatments were made using one-way ANOVA and 
post hoc comparisons using Duncans New Multiple Range Test *p<0.05 vs 
Control untreated group +p<0.05 vs Vehicle injected group.
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Figure 12. Total flu id consumption from conception to birth (prenatally) and 
from birth to the testing day (postnatally). Histograms represent mean and 
vertical bars, s.e. mean for the control untreated (unfilled), vehicle treated 
(dotted), diazepam Img/kg treated (stripes) and diazepam lOmg/kg treated 
(filled) groups at (a) 20 and (b) 25 days of age. Values are the means o f 3-4 
fitters for each treatment group. Statistical comparisons w ithin each series o f 
treatments were made using one-way ANOVA and post hoc comparisons using 
Duncans New Multiple Range Test *p<0.05 vs Control untreated group 
+p<0.05 vs Vehicle injected group.
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Figure 13. Effect o f chronic maternal a) vehicle b) diazepam (Img/kg) and c) diazepam 
(lOmg/kg) on tail immersion response latencies in 10 day old rat pups. (O) saline treated, 
unstressed (# ) saline treated, swim-stressed (□ ) naloxone (lOmg/kg, unstressed (■ ) naloxone 
lOmg/kg swim-stressed. Pre= pretest responses lOmin before swim stress. Values are the 
mean ±  s.e. mean of 6 - 8  animals. *p<0.05 vs unstressed control, 4-p<0.05 saline stressed vs 
naloxone stressed.
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Figure 14. Effect of chronic maternal a) vehicle b) diazepam (Im g/kg) and c) diazepam 
(lOmg/kg) on tail immersion response latencies in 15 day old rat pups. (O) saline treated, 
unstressed (# ) saline treated, swim-stressed (□ ) naloxone (lOmg/kg, unstressed (■ ) naloxone 
lOmg/kg swim-stressed. Pre= pretest responses lOmin before swim stress. Values are the mean 
±  s.e.mean of 6 - 8  animals. *p<0.05 vs unstressed control.
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Figure 15. Effect of chronic maternal a) vehicle b) diazepam (Img/kg) and c) diazepam 
(lOmg/kg) on tail immersion response latencies in 20 day old rat pups. (O) saline treated, 
unstressed (# ) saline treated, swim-stressed (□ ) naloxone (lOmg/kg, unstressed (■ ) naloxone 
lOmg/kg swim-stressed. Pre= pretest responses lOmin before swim-stress. Values are the mean 
±  s.e. mean of 6 - 8  animals. *p<0.05 vs unstressed control, +p<0.05 saline stressed vs naloxone 
stressed.
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Figure 16. Effect o f chronic maternal a) vehicle b) diazepam (Im g/kg) and c) diazepam 
(lOmg/kg) on tail immersion response latencies in 25 day old rat pups. (O) saline treated, 
unstressed (# ) saline treated, swim-stressed (□ ) naloxone (lOmg/kg, unstressW (■ ) naloxone 
lOmg/kg swim-stressed. Pre= pretest responses lOmin before swim stress. Values are the mean 
± s.e. mean o f 6 - 8  animals. *p<0.05 vs unstressed control, +p<0.05 saline stressed vs naloxone 
stressed.
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Figure 17. Specific binding for InM  concentration o f [^H ] DAGO. Histograms 
represent mean and vertical bars, s.e. mean, in brain regions : Cor (cortex), Med 
(medulla), Str (striatum). M id (midbrain). Hyp (hypothalamus) and Hip 
(hippocampus) of 20 day old vehicle (unfilled) and diazepam lOmg/kg (filled) 
treated rats. Statistical comparisons between the groups were made using unpaired 
Student's t-test. No significant differences between groups in all the regions.
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Figure 18. Plasma corticosterone concentration (jXg/lOOml). Histograms 
represent mean and vertical bars, s.e. mean of 2 0  day old vehicle (unfilled) and 
diazepam lOmg/kg (filled) treated rats. Values are the means o f 4 rats fo r each 
group. Sal. Unst. = saline injected unstressed; Sal. Str. = saline injected swim 
stressed. NLX Unst, = naloxone injected unstressed; NLX Str. = naloxone 
injected swim stressed. Statistical comparisons between the groups were made 
using unpaired Student's t-test. No significant differences between diazepam and 
vehicle treated groups.
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3.4 D ISCU SSIO N
A great deal of attention has been paid in recent years to some chemical agents that are 
injected during pregnancy with the possibility of a short or long term neurobehavioural 
alterations that could manifest in the neonate. Benzodiazepines are among such agents 
with a widespread record of use and abuse especially for their sedative-hypnotic and 
anxiolytic properties. Sedative and hypnotic drugs can produce maternal under 
nutrition as a side effect (Greizerstein and Aldrich, 1983). Although, some o f the 
developmental exposure studies to diazepam have reported deficits in body weight gain 
(Ryan and Pappas, 1986; Su and Yu, 1986) others at doses similar to those used in our 
study have shown no litter size or weight gain differences (Gai and Grimm, 1982; Lall 
and Sahoo, 1990; Cagniano et al., 1990). The lack of overt nutritional effects o f pre- 
and postnatal diazepam treatment in our study negates the possibility that effects on the 
behavioural responses result from developmental under nutrition. The lack o f effect on 
body weight is perhaps surprising since it is well known that benzodiazepines cause 
hyperphagia and hyperdipsia and indeed that this effect is reversed by opioid 
antagonists (fo r reviews see Cooper, 1983b, 1983c). There was evidence of 
hyperdipsia in diazepam-treated animals, in part probably associated w ith the 
dipsogenic effects of alcohol used as a vehicle for the drug. The lack o f body weight 
effects may reflect the overriding metabolic demands upon nursing mothers and accord 
with others who have failed to see effects o f diazepam on body weight in pregnant rats 
(Massotti et al., 1980). Also w ith respect to the neonates, the im m aturity of 
benzodiazepine and opioid systems may be important; for example effects o f opioid 
antagonists on ingestive behaviour are not evident until 14 days (Aroyewun and Barr, 
1982).
In common with the results o f previous study in naive animals described in  section 2.3, 
vehicle treated rats exhibit a small level o f SIA as early as postnatal day 10. Further, in 
pre- and postweanling rats (20 and 25 days) the reversal of SIA by naloxone accords 
with opioid receptor mediation of this behaviour (Jackson and Kitchen, 1989a, Kitchen
113
and Pinker, 1990). However in diazepam-treated animals at 20 days of age, although 
SIA is present, its lack o f reversal by naloxone suggests that non-opioid receptor 
mechanisms mediate this effect. Clearly this points to developmental toxicity o f 
diazepam upon opioid systems. It is an effect which persists through to the 
postweanling period and indeed in the animals treated with lOmg/kg diazepam there is a 
blunting o f the SIA response, showing disruption o f stress-mediated behaviour even 
when diazepam is no longer being administered. Whether the effect o f chronic perinatal 
diazepam is an action upon opioid receptor development is uncertain. Diazepam and its 
major metabolite is reported to have no affinity fo r ]4- or K-opioid receptors (Rosland 
and Hole, 1990b). Others (Rattan et al., 1991) have shown that midazolam, another 
benzodiazepine had a dual effect on the binding o f opioid ligands to their receptors, 
with potentiation and inhibition observed at lower and higher doses respectively. The 
latter action is believed to result in the decrease in morphine antinociception. However, 
pre- and post-natal diazepam treatment has been shown to cause a small decrease in k- 
opioid receptors (Watanabe et al., 1983) as well as a small down regulation o f 
benzodiazepine receptors themselves (Livezey et al., 1985; Rothe and Bigh, 1988), 
although it  should be stressed that others have failed to observe changes in  
benzodiazepine sites after diazepam treatment (Massotti et al., 1980; Laitinen et al., 
1986). In this study, perinatal diazepam treatment did not significantly alter //-opioid 
(DAGO) binding compared with control in all o f the brain regions studied. This 
suggest that the effect of diazepam could not have been due to disruption o f //-opioid 
receptor development although it should be noted that there was marked variability in 
binding measures. It is also unlikely to be due to disruption o f the HPA function since 
levels o f plasma corticosterone indicates no significant differences between diazepam 
and vehicle treated rats, which may suggest that p-endorphin secretion by the pituitary
cells was also unaffected by diazepam.
Whether an interaction o f diazepam with opioid systems is manifested in the CNS or 
the spinal cord is not possible to determine from the current evidence, but it  should be 
stressed that the tail immersion response used to assess SIA is recognised to be 
predominantly a spinally mediated reflex. Furthermore the effect o f benzodiazepines in
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modulating pain reflexes (Juma, 1984; Niv at al., 1988; Boulter et al., 1991) as well as 
opioid antinociception (Moreau and Fieri, 1988; Yanez et al., 1990; Rattan et al., 1991) 
stems from its action at the spinal level.
On the possibility of a non-opioid involvement in the mediation o f the SIA, it should be 
noted that disruption o f cholinergic, GABAergic, 5-hydroxy try  ptami ne and 
noradrenergic systems (Simmons et al., 1984; Frieder and Grimm, 1985; Kellogg and 
Retell, 1986) after prenatal diazepam has been shown and these have been implicated as 
'downstream neurotransmitter' in the mediation o f SIA (see Bodnar, 1984). Thus the 
toxic effect o f diazepam does not necessarily have to reflect a direct action o f opioid 
systems.
Specific acute interactions of benzodiazepines upon opioid mediated SIA have been 
shown in the adult. Benzodiazepine agonists inhibit and benzodiazepine antagonists 
potentiate footshock-induced antinociception (Rovati et al., 1990) and both
benzodiazepine ligands inhibit antagonism o f SIA by naloxone. This observation is
that
consistent with the present chronic ontogenetic study which show^diazepam treatment 
blocks naloxone reversal of SIA and in the adult, Rovati et al., (1990) have shown 
diazepam reverses stress-induced down regulation o f opioid binding sites labelled with 
pH ] naloxone. It should be noted however that the nature of stressor is important in 
determining the effect of the benzodiazepines, as cold water swim stress antinociception 
is potentiated by diazepam (Leitner and Kelly, 1984) and tail shock antinociception can 
be unaffected or reduced by diazepam, dependent on the duration o f shock (Maier et 
al., 1990). Further, Alieva et al., (1987) showed prenatal oxazepam exposure in mice 
had no effect on morphine antinociception in neonates but delayed morphine 
hyperactivity thus suggesting selective effects o f benzodiazepines on opioid mediated 
behaviours. I t  can now be added that stress-induced antinociceptive responses are 
modified by benzodiazepine treatment and this differential effect on antinociceptive 
mechanisms accords with Bodnar et al., ( 1980) who showed chronic pretreatment o f
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adult rats w ith chlordiazepoxide attenuated cold water swim antinociception without 
affecting morphine antinociception.
In conclusion perinatal exposure to diazepam modifies opioid mediated SIA further 
confirm ing the interrelationship between opioid and benzodiazepine systems and 
showing that maternal diazepam exposure causes opioid system dysfunction. The 
depressed antinociception in 25 day old neonate rats after perinatal diazepam calls for 
caution in their use during pregnancies and the supposed usefulness in  disorders 
associated with pain.
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CHAPTER FOUR
4 ONTOGENESIS OF OPIOID FUNCTIONS IN WEANED AND 
NON-WEANED RATS
4.1 EFFECT OF DELAYED WEANING ON SIA
4.1.1 Introduction
In the diazepam studies described in chapter three, pilot experiments w ith the control 
untreated group showed that animals le ft w ith their mothers beyond the period o f 
weaning responded differentially to opioid antagonists in relation to reversal o f SIA. 
Previous pharmacological experiments in our laboratory had shown that the opioid 
receptor subtype which operates the opioid form o f SIA differs in the neonate in 
comparison with the adult. Evidence from previous studies with naloxone and the ô- 
selective antagonists IC I, 174 864 and naltrindole show that up to postnatal day 20 
swim SIA is mediated by //-receptors but by day 25, it  is predominantly ô-sites which 
operate this behaviour (Jackson and Kitchen, 1989a; Kitchen and Pinker, 1990). The 
mechanisms underlying this receptor transition remain to be elucidated and the 
possibility was considered that the behavioural stimulus o f weaning (at day 2 1 ) might 
be an important factor in the change. The studies reported in this chapter show that 
weaning is a critical element in initiating the transition from //- to ô-opioid receptor 
operation o f swim SIA and that delay of weaning can temporarily delay the receptor 
change. The aim o f the experiments were to study the effect of delayed weaning on 
opioid receptor subtype control o f SIA using selective opioid antagonists.
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Figure 19 Chemical Structures of alfentanil, naloxone and naltrindole
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4.1.2 M ethodology
4.1.2.1 Animals and Experimental Conditions
The animals and experimental conditions were as described in section 2.2.1. However, 
in the experiments described in this chapter, both weaned and non-weaned groups o f 
neonate rats were used. The weaned groups are those animals that were permanently 
separated from their mothers at the weaning age o f 2 1  days and the non-weaned groups 
are those animals left together with their mothers beyond the weaning age, until the day 
o f experimental testing (postnatal day 25 and 30). Therefore, for all experiments 
performed with non-weaned (25 and 30 day old) animals, pups remained w ith their 
mother at all times except during drug administration, swim stress or nociceptive testing 
only, to minimise stress to the pups due to maternal deprivation.
4.1.2.2 Swim Stress Procedures and Nociceptive Testing
Antinociception was induced in the rats by the swim stress procedures as described in 
section 2.2.2. Nociceptive responses were recorded immediately before the 
administration o f opioid antagonists, naloxone and naltrindole and at 1 ,5 ,10 ,15  and 
30 min. follow ing swimming stress by the use o f tail immersion test described 
previously in section 2.2.3. In some experiments the //-receptor agonist alfentanil, 
was administered (without swim stress) to induce antinociception and nociceptive 
responses assessed at 2, 5, 10 and 15 min after alfentanil. Reversal by naltrindole 
(given 1 0  min prioyto alfentanil) was also assessed.
4.1.3 Drugs and Statistical Analysis
Drugs used were alfentanil (Janssen Pharmaceuticals), naltrindole (Research 
Biochemicals Incorporated) and naloxone (D upont);Their c h e m ic a l s t r u c t u r e s
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are shown in figure 19. Solutions of the drugs were made 
by dissolving required quantity in appropriate volumes o f 0.9% saline. Statistical
comparisons within each series o f treatments were made using one-way ANOVA and
post hoc comparisons with Duncans New Multiple Range Test using the SuperANOVA
package for the Macintosh.
4.1.4 R esu lts
Naloxone (10 mg/kg) and naltrindole (1 or 5 mg/kg) had no significant effect on 
nociceptive latencies in unstressed 25 day old animals from either weaned or non- 
weaned groups (Figs 20-22).
The magnitude o f SIA in response to swimming was similar in  both weaned and non- 
weaned groups (latency 6-7s; Figs 20-22). In 25 day old rats naloxone at 10 mg/kg 
significantly attenuated swim SIA in weaned and non-weaned animals. (Fig 20). In 
contrast, naltrindole (Img/kg) had no effect on swim SIA in 25 day old non-weaned 
groups (Fig 21b) but in weaned animals naltrindole partially and significantly attenuated 
SIA (Fig 21a). In 25 day old rats treated with 5mg/kg naltrindole, swim SIA was 
totally abolished in weaned animals but unaffected in non-weaned rats (Figs 22a and 
b). In 30 day old non-weaned rats naltrindole (5mg/kg) abolished the swim SIA (Fig 
23).
Antinociceptive responses to the //-agonist alfentanil (60//g/kg) in 25 day old rats were 
unaffected by naltrindole at 1 mg/kg (Crook et al., 1992) but were partia lly and 
significantly antagonised by naltrindole at 5 mg/kg (Fig 24).
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Figure 20. Effect of naloxone (lOmg/kg) on antinociception 
induced by a 3min swim in (a) 25 day old weaned and (b) 25 
day old non-weaned rats. Values represents mean ± s.e. 
mean for groups of 6 -8  animals. (O)Saline injected, 
unstressed; ( • )  Saline injected swim-stressed; (□ ) naloxone 
lOmg/kg unstressed; (■) naloxone lOmg/kg swim-stressed. 
Pre = pretest responses 10 min before swim-stress. *p<0.05 
swim-stressed vs appropriate unstressed control; +p<0.05 
saline treated, swim stressed vs naloxone treated swim- 
stressed.
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Figure 21. Effect of naltrindole (Img/kg) on antinociception 
induced by a 3min swim in (a) 25 day old weaned and (b) 25 
day old non-weaned rats. Values represents mean ± s.e. mean 
for groups of 6 -8  animals. (O)Saline injected, unstressed; (# ) 
Saline injected swim-stressed; (□ ) naltrindole Img/lcg 
unstressed; (■ ) naltrindole Img/kg swim-stressed. Pre = 
pretest responses 10 min before swim-stress. *p<0.05 swim- 
stressed vs appropriate unstressed control; +p<0.05 saline 
treated, swim stressed vs naloxone treated swim-stressed.
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Figure 22. Effect of naltrindole (5mg/kg) on antinociception 
induced by a 3min swim in (a) 25 day old weaned and (b) 25 
day old non-weaned rats. Values represents mean ± s.e. mean 
for groups of 6 - 8  animals. (0 )Saline injected, unstressed; ( • )  
Saline injected swim-stressed; (□ ) naltrindole 5mgÀ^g 
unstressed; (■ ) naltrindole 5mg/kg swim-stressed. Pre = 
pretest responses 10  min before swim-stress. *p<0.05 swim- 
stressed vs appropriate unstressed control; +p<0.05 saline 
treated, swim stressed vs naloxone treated swim-stressed.
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F i^ re  23. Effect of naltrindole (5mg/kg) on
antinociception induced by a 3min swim in 30 day old 
non-weaned rats. Values represents mean ± s.e. mean for 
groups o f 6 - 8  animals. (O)Saline injected, unstressed; 
( • )  Saline injected swim-stressed; (□ ) naltrindole
5mg/kg unstressed; (■ ) naltrindole 5mg/kg swim-
stressed. Pre = pretest responses 10 min before swim- 
stress. Treatment groups compared using ANOVA and 
Duncans New Multiple Range Test. *p<0.05 swim- 
stressed vs appropriate unstressed control; +p<0.05
saline treated, swim stressed vs naloxone treated swim- 
stressed.
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Figure 24. Effect of naltrindole (5mg/kg) on antinociception induced 
by alfentanil (60pg/kg). Values represent mean ±  s.e.mean o f 6  
animals (O) Saline injected;( • )  naltrindole alone (5mg/kg); (□ ) 
alfentanil alone (60^g/ig); (■ ) alfentanil (60|Lig/kg) + naltrindole 
(5mg/kg). Pre=pretest responses 10min before alfentanil 
administration. Treatment groups compared using ANOVA and 
Duncans New Multiple Range Test *p<0.05 alfentanil vs alfentanil + 
naltrindole.
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4.1.5 D iscussion
In common w ith previous findings in our laboratory (Jackson and Kitchen 1989a; 
Kitchen and Pinker 1990), swim SIA in 25 day old weaned rats is partially reversed by 
both naltrindole (1 mg/kg) and by naloxone (10 mg/kg). This dose o f naltrindole is 
selective for antagonism of ô-sites at this age (Kitchen and Pinker, 1990; Crook et al.,
1992) and naloxone at this dose has blocking activity at both pi- and 6 - opioid receptors 
(Paterson et al., 1983; James and Goldstein, 1984). Antagonism o f SIA by naloxone 
could therefore be ascribed to pt- or ô- receptor blockade or to a mixture o f antagonism 
at both sites. The complete reversal o f swim SIA by naltrindole at 5 mg/kg in weaned 
animals might suggest that ô-sites exclusively mediates this response but at this dose 
naltrindole may have some //-antagonist activity (Fig 24) and it is therefore consistent 
with the previous proposal that both ô- and to some degree //-sites are involved in swim 
SIA at day 25 (Jackson and Kitchen, 1989a; Kitchen and Pinker., 1990).
The complete reversal o f swim SIA by naloxone (lOmg/kg) in non-weaned animals 
points to opioid receptor mediation but it is clearly not ô-receptors which are operative 
as naltrindole is without effect at either 1 or 5 mg/kg. The profile o f sensitivity to these 
antagonists is consistent with the profile observed in 2 0  day old preweanling animals 
where the evidence points to //-receptors mediating swim SIA (Jackson and Kitchen, 
1989a). It therefore seems probable that delaying weaning delays the transition from //- 
to Ô- receptor operation of this behaviour. I t  is not possible to totally discount a 
contribution from K-sites to warm-water swim SIA in non-weaned animals but as 
previous studies have failed to show K-receptor involvement in this behaviour in both 
mice and rats (Hart et al 1983; Jackson and Kitchen, 1989a) this seems unlikely. It 
should be noted however that levels o f dynorphin in the CNS are not affected by 
restraint stress (Morley et al., 1982) but can be shown to be decreased in response to 
cold water swim stress (Vaswani et al., 1988). As dynorphin is recognised as an 
endogenous ligand for the K-receptor (Chavkin et al., 1982) a contribution o f K-sites to 
some types o f SIA remains a possibility (Panerai et al., 1984). Indeed, a recent report
127
(Menendez et al., 1993) has implicated spinal K-opioid receptors in a type of footshock- 
induced antinociception in mice.
A t the normal age o f weaning (21 days) around 75% of the total adult complement o f ô- 
sites are developed in the brain whilst //- and k - sites are fu lly  mature (Spain et al., 
1985; McDowell and Kitchen, 1986; Kitchen et al., 1990, Kitchen et al., 1992). This 
raises the possibility that a subpopulation of ô-opioid receptors might develop in the 
fourth postnatal week and that ordinarily weaning is the stimulus for this development. 
Evidence for 0-receptor heterogeneity is increasing (Jiang et al., 1991; Mattia et al., 
1991, 1992; Sofuoglu et al., 1991, 1992) and the sensitivity o f putative ô i and Ô2  sites 
to antagonism by naloxone and naltrindole show differences in 25 day old rats (Crook 
et al., 1992). Further, it  has recently been reported that in mice swim SIA is mediated 
by the Ô2  subtype (Vanderah et al., 1992) and it may be that weaning influences the 
development o f a ô-receptor subtype. A t a biochemical level weaning has been shown 
to activate enzyme systems at the mRNA transcription level (Girard et al., 1971; Coupe 
et al., 1990) and a similar effect at the genetic level for neurotransmitter receptors is 
thus feasible. An alternative possibility is that weaning is instrumental in  coupling Ô- 
sites to second messengers and that this phenomenon normally accounts fo r the 
receptor transition. In support o f this possibility, although adrenergic and cholinergic 
stimulation of cyclic nucleotides is fully developed at birth and two weeks respectively, 
morphine stimulated changes in cAMP and cGMP do not peak until day 21 (Muraki et 
al., 1983). Further, studies w ith selective opioid receptor agonists reveal that ô- 
mediated inhibition o f dopamine sensitive adenylate cyclase does not begin to be 
effective until day 14 whereas pi effects are evident during gestation (De Vries et al., 
1990). The effect of delayed weaning is temporary as naltrindole is able to block swim 
SIA at day 30 and presumably other influences eventually precipitate the change in 
receptor operation in the absence of the weaning process.
delaying
In this study therefore it has been shown that^ weaning delays the transition from pi- to 
ô-receptor control o f swim SIA by between 5 to 10 days in the rat. Thus the weaning
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process appears to have an important influence on CNS opioid receptor operation of 
biological responses although the molecular mechanisms underlying these in vivo 
effects remain to be elucidated. The possibility that weaning activates the development 
o f a subtype of the ô-receptor has been addressed in Section 4.2.
4.2 WEANING AND 5-MEDIATED ANTINOCICEPTION
4.2.1 Introduction
The results o f previous studies (Section 4.1), have shown that delay o f weaning can 
prevent the transition from pi- to Ô-opioid receptor control o f SIA between day 20 and 
day 25 and that the behavioural stimulus o f weaning is responsible for this transition. 
Binding studies from our laboratory (Me Dowell and Kitchen, 1986) have shown that 
25% of ô-receptors do not develop until after weaning. Further, it  has recently been 
reported that in mice, swim SIA is mediated by the Ô2-receptor subtype (Vanderah et 
al., 1992). This led to the hypothesis that weaning may be the stimulus fo r the 
expression o f a ô-opioid receptor subtype which develops in the fourth postnatal week. 
In order to verify this hypothesis the present experiments were designed to study the 
antinociceptive potency of two ô-selective agonists, [D-Ala^] - deltorphin I (DELT I) 
and [D-Ser^, Leu^» Thr^ enkephalin (DSLET) in 25 day old weaned and non-weaned 
rats, since previous studies with these two agonists in our laboratory (Crook et al., 
1992; 1993) have shown that they discriminate between the putative ô i- and 0 2 - 
receptors respectively. In addition, antagonism o f the antinociception by the Ô2 - 
selective antagonist naltriben was studied.
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4.2.2 M ethodology
Animals and experimental conditions were as previously described in section 2.2.1 but 
the rats were maintained in litters o f ten pups, and both weaned and non-weaned rats 
were used as described in section 4.1.2.1. Nociceptive testing were also as described 
previously in section 2.2.3. Nociceptive reaction times were measured 15 min before 
and at 2, 5, 10 and 15 min after the administration o f the opioid agonists. Where 
studied, naltriben was injected 10 min before agonist administration. In experiments 
performed with non-weaned (25 day old) litters, pups remained with the mother except 
during drug administration or nociceptive testing. On the day o f testing, ammals were 
divided into saline, agonist alone, or agonist + antagonist treated groups.
Plasma corticosterone levels were determined in 25 day old weaned and non-weaned 
neonate rats as described previously in section 2.2.5.
This part o f the work (4.2) was carried out in collaboration w ith Tracy J. Crook.
Figure 25 Chemical Structure of Naltriben
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4.2.3 Drugs and Statistical Analysis
The drugs used were [D-Ser^, Leu^, Thr^] enkephalin (DSLET), obtained from 
Cambridge Research Biochemical, D-Ala^ deltorphin I (DELT I) from Dupont and 
naltriben, a g ift from Dr P.S. Potoghese (University o f Minnesota). Stock solutions o f 
the drugs were made at 1 mg/ml (except where higher concentrations were required) in 
0.9% saline and administered i.p. in dose volume no greater than 0.1ml. Part o f the 
aliquots were frozen for further use. Stock solutions were subjected to freeze-thawing 
only once.Thechemica 1 s t r u c t u r e  o f  n a l t r  ib e n  i s  show nin  fig>25 . 
Antagonism o f the antinociceptive responses to the 0-agonists was analysed at each 
time point by one-way ANOVA and post hoc comparisons with Duncans New Multiple 
Range Test using the SuperANOVA package for the Macintosh.
4.2.4 Resu lts
In weaned rats DSLET (0.25-1 mg/kg) produced significant dose related 
antinociception (Fig 26a) with a peak response latency o f 4.7s. In non-weaned 
animals, DSLET at the same doses had no effect and the maximal response latency was 
equivalent to the saline control latency of 2.5s (Fig 26b). In contrast, DELT I (0.01- 
0 .1  mg/kg) produced significant dose related responses in both weaned and non- 
weaned rats w ith peak response latencies of 5.7s in the weaned and 4.7s in non- 
weaned animals (Figs 27a and b). Naltriben (5mg/kg) abolished the antinociceptive 
responses to DSLET in weaned rats (Fig 28a) but had no effect on response latencies to 
DELT I in either weaned or non-weaned groups (Fig 28b and c).
Serum corticosterone concentration in the 25 day old weaned and non-weaned animals 
were not significantly different , but the levels were found to be 25% (saline 
unstressed), 41% (saline stressed), 24% (naltrindole unstressed), and 35% (naltrindole 
stressed) higher in the weaned than in the non-weaned groups.(figure 29).
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Figure 26. Antinociceptive effects of DSLET in 25 
day old weaned (a) and non-weaned (b) rats. Values 
are the mean ± s.e. mean of six observations (O) 
Saline, (# ) DSLET 0.25mg/kg, (□ ) DSLET 0.5mg^g, 
(■ ) DSLET 0.75mg/kg, (A) DSLET Img/kg. One-way 
ANOVA and post-hoc comparisons using Duncans 
New Multiple Range test versus saline control groups at 
peak antinociception (5 min). p<0.05 all doses for 
weaned, not significant for non-weaned animals.
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weaned (a) and non-weaned (b) rats. Values are the mean ±  
s.e. mean o f six observations (O) Saline, ( • )  DELT I  0.01 
mg/kg, (□ ) DELT I  0.025 mg/kg, (■ ) DELT I  0.05 mg/kg, 
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comparisons using Duncans New Multiple Range test versus 
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all doses.
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Figure 28. Effect of naltriben (5|ig/k:g) on the antinociceptive effects o f (a) DSLET in 
weaned 25 day old rats, (b) DELT I in weaned 25 day old rats and (c) DELT I  in non- 
weaned 25 day old rats. Values are the mean ± s.e. mean of six observations. (O) 
Saline;(#) DSLET 0.25mg/kg, DELT I O.Olmg/kg; (□ ) DSLET 0.5mg/kg, DELT I 
0.025mg/kg; (■ ) DSLET 0.75mg/kg, DELT I 0.05mg/kg; (A ) DSLET Img/kg, DELT I 
O.lmg/kg. One-way ANOVA and post hoc comparisons using Duncans New M ultiple 
Range test versus equivalent treatment groups in absence of naltriben at peak 
antinociception (5 min). DSLET (aU doses weaned animals) p<0.05; DELT I  (all doses 
weaned and non-weaned animals) not significant.
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Figure 29. Plasma corticosterone concentration (ng/lOOml). Histograms 
represent mean and vertical bars, s.e. mean of weaned (unfilled) and non 
weaned (filled) 25 day old rats. Values are the means of 4 rats fo r each 
group. Sal. Unstr. = saline injected unstressed; Sal. Str. = saline injected 
swim stressed; NTI Unst. = naltrindole injected unstressed; N TI Str. = 
naltrindole injected swim stressed. Statistical comparisons between the 
groups were made using unpaired Student’s t-test. No significant difference.
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4.2.4 D iscussion
Additional support for ô-opioid receptor heterogeneity (Sofuoglu et al., 1991; Jiang et 
al., 1991; Negri et al., 1991; W ild et al., 1991; Mattia et al., 1991, 1992; Tiseo and 
Yaksh, 1993) and in vivo differentiation o f ô-subtype responses (Crook et al., 1992;
1993) has been provided by the results o f this study. However, classification o f 
compounds as putative ô i- and Ô2 -receptor agonists has been based on in vivo studies 
in the mouse (Mattia et al., 1992) which point to deltorphin analogues being selective 
for 0 2 -receptors. This classification does not hold for the current and previous studies 
(Crook et al., 1992; 1993) in young rats as the profile of activity o f DELT 1 and the 
lack o f reversal by a low dose o f naltriben, which is a competitive Ô2 -antagonist 
(Sofuoglu et al., 1991), suggest that the effects of DELT 1 are mediated by ôi-receptors 
in the rat. In this study putative ô-subtype selective agonists produce distinct responses 
in weaned and non-weaned 25 day old rats. The complete lack o f activity o f DSLET in 
non-weaned animals is in sharp contrast to the marked antinociception observed in 
weaned rats and points to the absence or functional disability o f that ô-opioid receptor 
subtype for which DSLET is selective. Since no distinction could be observed between 
weaned and non-weaned animals in their response to DELT 1, it implies that the 
receptor mediation of antinociception by this agonist differs from that for DSLET and 
support the proposed hypothesis that these two agonists exert their antinociceptive 
effects via different sites in the rats. Furthermore the complete antagonism of the 
antinociceptive effect of DSLET by a low dose of NTB and the lack o f its antagonistic 
effect on responses to DELT 1 at similar dose confirms ô i (for DELT 1) and Ô2  (fo r 
DSLET) subtype selectivity profile of these agonists.
The findings that DELT I is antinociceptive in both weaned and non-weaned rats while 
DSLET is antinociceptive in the weaned but not in the non-weaned rats support the 
notion that weaning activates a system which is responsible for mediating the effects o f 
DSLET, unlike the DELT I antinociception which is not affected by the weaning 
process. Taken together with the report o f previous studies that ô-receptors mediate 
SIA in postweanling animals (Kitchen and Pinker 1990, Section 4.1 o f this thesis) and
136
the suggestion that Ô2-receptor subtype mediates swim-SIA in adult mice (Vanderah et 
al., 1992) , it  is feasible that the ô-receptor that becomes involved in SIA in 
postweanling period in the rat as in the mouse is the Ô2-subtype. A t the molecular 
level, it  is most likely that weaning either initiates the global developmental expression 
o f a ô-subtype for which DSLET has a high affin ity or activates a specific regional 
expression o f ô-receptors which are essential for antinociception produced by DSLET 
but not that produced by DELT I. Alternatively, weaning could initiate coupling o f ô- 
receptors to second messengers allowing specific ô-mediated responses at the cellular 
level. It should also be noted that pharmacokinetic studies in the weaned and non- 
weaned rats in relation to the effect o f ô-opioid drugs havcnot been carried out.
Differences in absorption distribution or metabolism which could affect drug-receptor
the
interaction a t^ llu la r level remains a possibility.
It  has been suggested that environmental events at specific times o f development could 
result in long term changes of neuropeptide receptors (Insel et al., 1990). Furthermore, 
a variety o f physiological processes in the infant rat are believed to be regulated by 
specific factors o f maternal origin ( Rosenfeld et al., 1992). Cardiac rate, fo r example, 
has been shown to decrease following removal o f the mother and the decrease was 
reversed by providing the infant with m ilk (Hofer, 1973; 1984). A similar regulatory 
role has been demonstrated for respiratory rate, as well as growth hormone and 
orthinine decarboxylase secretion (Schanberg et al., 1984; Kacsoh et al., 1990; Kuhn 
et al., 1990). Insel et al., (1990) have shown that prenatal stress caused a decrease in 
[^H] DAGO binding in discrete brain regions largely due to reduced receptor number 
rather than their affinity. Kinsley et al., (1988) have sim ilarly reported that prenatal 
stress alters morphine and stress-induced antinociception in male and female rats. 
These findings have raised the possibility that the stressful events o f weaning could 
influence receptor transition and subsequent development. In  support o f this 
hypothesis, higher levels of corticosterone were observed in all the treatment groups o f 
the weaned th a n  the non-weaned animals (fig  29) suggesting that some degree o f 
stress is associated w ith this process. It  is also possible that the raised serum
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corticosterone found in the weaned rather than the non-weaned neonate rats might be an 
important factor in these developments. Previous studies (Rosenfield et al., 1992) have 
shown sim ilarly that neonate rats exhibit a marked increase in  adrenocortical 
responsiveness to stress following maternal separation and that there appears to be a 
critical length o f deprivation (between 8-24hr) beyond which persistent changes in 
adrenocortical responsivity ensue. The raised corticosterone levels may be desirable for 
the receptor development as well as functional expression o f opioid receptors since 
glucocorticoids in moderate levels are among the essential trophic factors required for 
the development and subsequent growth o f neuronal systems and transmitters in the 
CNS. (Sapolsky and Meaney, 1986). It is therefore feasible that the stressful events 
of weaning may lead to the functional expression of ô-receptors and subtypes identified 
to be important in the mediation o f SIA in postweanling rats (Kitchen and Pinker, 
1990) and in adult mice (Vanderah et al., 1992). From the current evidence it  is not 
possible to determine i f  weaning activates the receptor or the coupling system, but with 
the recent cloning o f the ô-receptor (Evans et al., 1992; Keiffer et al., 1992) showing 
that the necessary mechanism for alternative splicing as a route to receptor subtypes is 
present in the gene, it  seems probable that weaning turns on the expression o f a ô- 
receptor subtype.
This data provides yet further indirect evidence that ô-receptor subtypes are 
differentially expressed and suggest that weaning may be the primary stimulus fo r the 
expression o f the Ô2-subtype in the developing rat.
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CHAPTER 5
GENERAL DISCUSSION
Ontogenetic study of swim-SIA has revealed the absence o f opioid mediated forms o f 
this behaviour in the 2 and 5 day old neonate rat. However, an age related 
antinociception was clearly evident in 10,15, 20 and 25 day old rats. Observation o f 
swim-SIA in 2-10 day old rats has been made possible with the development and use o f 
a harness device (as described in section 2.2.2) to aid swimming. Naloxone's ability to 
significantly reverse the swim-SIA indicates that the antinociception involves mediation 
by opioid receptors. Indeed reversibility o f physiological and pharmacological 
functions o f opioids by opioid antagonists infers opioid system involvement. The 
absence of swim-SIA in 2 and 5 day old neonate rats is associated with the immaturity 
o f the pain inhibitory system. Research on the ontogenesis o f opioid neurotransmitter 
systems reveals their state of immaturity at birth b u t gradually reach mature levels 
after an extended period o f postnatal development, which is about one month in the rat 
(Hamm and Knisely, 1987). In their studies, Hamm and Knisely, (1987) have shown 
that the non-opioid form of cold water swim-SIA is also present in 10 day old rats. 
This antinociception is hormonally mediated and dependent on the HPA system. 
Antinociception induced by exogenously administered opioids has also been
demonstrated as early as day 2 in the rat (McDowell and Kitchen, 1987; Helmstetter,
e t a l.^
1988; Blass^l993). This implies that endogenous opioid systems are functional at 
least in terms o f the availability of receptors and their potential fo r binding an 
exogenous opioid and transducing the signal arising from that change into behavioural 
modulation. It  thus appear that because of the immature state of the endogenous pain 
inhibitory system in 2  and 5  day old rats and/or their state o f hyporesponsiveness to 
stress, activation o f the opioid system necessary to release endogenous opioids and to 
elicit antinociception is not achievable by the swim stress.
The present ontogenetic studies are important in being the first to investigate swim-SIA 
(using swimming harness) as early as day 2  in the rat and to report that this form o f
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antinociception is absent in 2 and 5 day old neonate rat. Furthermore these findings are 
in support o f the existence o f a stress hyporesponsive period in  the neonate 
(antinociception being a stress-mediated response) which is a period characterised by 
relative inactivity o f the adrenocortical axis upon exposure to stress (Sapolsky and 
Meaney, 1986). It is also a period that has been shown to coincide w ith reduced 
responsiveness o f the p-endorphin system to stress (Angelogianni and Gianoulakis, 
1989). This period, counter-intuitive it  may seem, is believed to be im portant 
particularly in the neonate to counteract the negative influences o f glucocorticoids on 
neonatal CNS growth and development (Sapolsky and Meaney, 1986). However, it is 
known that some components of the endogenous antinociceptive system are present and 
functional in the very early postnatal life  (Blass et al, 1993) and that the hormonally 
mediated system functions earlier in ontogeny than the non-hormonal antinociceptive 
system (Hamm and Knisely, 1987). More importantly, pain inhibition is one o f the 
many stress-mediated biological responses essential for the survival o f organisms. The 
questions that would arise from this study therefore are, how is antinociception elicited 
in the neonate rat when faced with environmental stress ? Is stress mediated pain 
inhibition completely unattainable in the neonate or is the activation o f this system 
stressor dependent ?. Answers to these questions w ill require more and detailed 
ontogenetic studies of SIA in a variety o f animal species and stress models. It w ill also 
require complete examination o f the maturational rate of the neuroendocrine systems 
that are critical for the production of antinociception and their relationship to stress 
application especially during the stress hyporesponsive period.
The results o f the diazepam study indicate that perinatal diazepam treatment causes 
disruption o f opioid mediated form of swim-SIA in the neonate rats. The disruption is 
evident from the lack o f reversibility o f the swim-SIA by the opioid antagonist, 
naloxone, a phenomenon not observed in neonates o f vehicle treated mothers. 
Although diazepam treatment did not affect the general growth pattern o f the neonates, 
the findings in this study is in agreement with several other investigators who reported 
that the long term use of benzodiazepines especially during pregnancy could result in
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some physical, neurochemical or neurobehavioural abnormalities in the offspring. Of 
particular interest was the observed persistent effect o f the drug 5 days after cessation 
o f treatment. In these animals, diazepam induced a significant suppression of the pain 
inhibitory system as there was no significant antinociception and the rats were 
hyperalgesic in the tail immersion test. Diazepam induced alterations have been shown
to persist at an age when the drug is no longer detectable in the brain (Simmons et al.,
the
1984) which suggeststhat treatment with this benzodiazepine du ring ^riod  o f division 
or differentiation o f cells in the brain could permanently affect neural development and 
function. It is of interest to note that the opioid peptides are among the most sensitive 
neurotransmitters/neurohormonal systems to toxic insults. For instance previous 
studies have shown that perinatal lead exposure in  rats sim ilarly disrupts the 
development of opioid systems (McDowell and Kitchen, 1988; Jackson and Kitchen, 
1989c; Kitchen and Kelly, 1993) Biological responses such as opioid mediated swim- 
SIA (rather than the non-opioid) is impaired by lead treatment. Furthermore opioid 
peptides such as enkephalins and ^-endorphin, the functions o f /< and ô-opioid 
receptors and other biological responses to opioids such as locomotion, tolerance, 
stress and hormonal responses have all been shown to be altered follow ing lead 
perinatal exposure (For review see Kitchen et al., 1993).
The toxic effects o f benzodiazepines on physical and neurobehavioural paradigms 
appear to vary depending upon the dose used and the time and duration o f prenatal 
exposure. Cagianno et al., (1990) who administered a daily s.e. injection o f diazepam 
(0.1 and Img/kg) from day 14-20 of gestation reported no differences in neonatal 
motality and weight gain compared with the control pups. However some behavioural 
alterations were evident in the early postnatal life  and during adulthood such as 
decreased locomotor activity, marked changes in the length o f ultrasonic calls, a 
behavioural test for emotionality, and a notable impairment o f copulatory activity in 
adult rats. With a higher dose of diazepam (2 0 mg/kg/day) in the last week of gestation, 
Lall and Sahoo, (1990) observed no alteration in litte r size but the birth weight and 
subsequent weight gain was significantly less than controls.
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The present study is the first ontogenetic study to show the toxic effect o f diazepam on 
opioid-mediated swim-SIA in neonatal rats whose mothers were treated perinatally. 
This finding is particularly important since benzodiazepines are widely employed in 
obstetrics and in chronic pain patients for alleviating anxiety and sleeping disorders. 
Since the neonate rats exhibited an increased sensitivity to pain at about an adulthood 
age o f 25 days, there is the possibility that the offspring of perinatally treated mothers 
w ill become less tolerant to the effect of environmental stressors and therefore more 
sensitive to noxious stimuli than offspring o f mothers that have had no diazepam 
treatment. W ith regard to pain management, there is now an increasing concern over
the use of benzodiazepines by chronic pain patients as they offer minimal benefit i f  any
dn
and in some patients have ^  fact exacerbated pain (King and Strain, 1990). In the long 
term use o f benzodiazepines therefore, the derived benefits must be weighed against the 
possible detrimental effects on the offspring pain control systems. I t  should be noted 
that there jare r e p o r t s  on behavioural and neurochemical evidence suggesting 
some interactions between benzodiazepines and the opioid systems. These studies have 
focused mainly on assessing the nature and mechanisms o f effects o f benzodiazepines 
and/or their antagonists on drug/stress induced antinociception after acute/single dose 
treatment before or following stress application. However the reported inconsistencies 
in the results obtained have rendered these investigations rather inconclusive. Future 
studies w ill therefore have to take into consideration all o f the suggested reasons 
responsible fo r the discrepancies. Future studies o f interactions especially on SIA 
should also focus on the developmental changes affecting the opioid system following 
perinatal benzodiazepine treatment. In this respect, an age by age analysis o f 
behavioural responses to selected drug challenges during critical stages o f neonatal 
ontogenesis could be made and may provide useful information on the way in which 
important behavioural functions are established at successive stages o f development 
between birth and adulthood.
Evidence for the existence of heterogenous pi and k  opioid receptor subtypes has 
accumulated due largely to the available ligands (agonists and antagonists) that are
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selective fo r these sites. In recent years evidence supporting m ultiple ô-opioid 
receptors has been presented by several investigators w ith the development o f 
selective ligands which until now were unavailable. Studies on the ontogenesis o f 
opioid functions in the weaned and non-weaned rats have been supportive to previous 
studies on ô-receptor heterogeneity by showing the existence o f two d iffe ren t 
populations of ô-receptors. This study is also the first to show that these receptor 
subtypes (ôi and ô% sites) develop differentially and independently in the rat. Firstly, 
this study has shown that the stimulus of weaning is a critical element in initiating the 
transition from //-Ô opioid receptor operation of swim-SIA since delaying the weaning 
process causes temporary delay in the transition. Secondly, using DELT I and DSLET 
as selective ligands for the ô i and Ô2 sites, it  has shown that the Ô2 -receptor subtype is 
absent or non functional in the non-weaned animals. On the other hand th i s 
population o f receptors is  present and clearly operational in the weaned animals 
implying that the stimulus associated with the weaning process is important fo r their 
development. Although the presence o f multiple ô-receptors has been established in 
both rats and mice, it should be noted that differences in the sensitivity of ô-selective 
agonists between the two species have been observed. In studies using rats. Crook et 
al., (1992) observed that the antinociceptive effect o f DELT 1 is mediated via a different 
ô-receptor subtype to that acted upon by DSLET. However DPDPE shows affin ity for 
both ô-receptor subtypes although preferential for DELT 1 receptor, being antagonised 
significantly by low dose o f NTI and a relatively higher dose o f NTB. In  contrast, 
Jiang et al., (1991) observed that in the mouse DPDPE antinociception is mediated via 
0 1 -receptor subtype being antagonised by DALCE and not 5NTI1. Jiang et al., (1991) 
also demonstrated that DELT 11 induced antinociception is 5NTI1 sensitive suggesting 
mediation via 0 2 -receptor subtype. Thus while DELT 1 is selective for ôi-receptor 
subtype in the rat (Crook et al., 1992), DELT II is selective for the Ô2 -receptor subtype 
in the mouse although the deltorphin analogues to which DELT I and DELT II are 
members have previously being claimed to be selective for the 0 2 -receptors (Mattia et 
al., 1992). The observed selectivity profile of these agonists may reflect species 
differences as opioid receptor constitution differ^from species to species. Structural
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differences between the two deltorphin analogues could also account for the differences 
in their selectivity for Ô sites in the rat and mouse. With respect to future studies on ô- 
receptor heterogeneity, the present finding that ô i  and Ô2  receptors develop 
differentially and independently in the pre- and postweanling periods respectively in the 
rat, may have a significant implication. Since DELT I and DSLET exhibited 
preferential affin ity fo r the respective ô-receptors in the non-weaned and the weaned 
animals, the pre- and postweanling rat may provide an invivo model for the screening 
o f potential agonists for the ô i and Ô2 receptor sites, as one or both o f these subtypes 
can be appropriately targeted for drug development. This could in the future lead to the 
development o f therapeutically useful drugs which act more specifically at these opioid 
receptor sites. The use of this approach must however await more studies especially in 
other animal species which should include regional binding and insitu hybridisation 
experiments to corroborate these findings at the molecular level to establish how 
weaning influences the activity and expression o f the Ô-receptor gene. Based on the 
different findings on opioid ô-receptor pharmacology, the brain and spinal cord may be 
viewed as two distinctive pharmacological environments and future studies employing 
the pre- and postweanling approaches should also investigate the development and 
functional roles o f the ô-receptors at these CNS areas.
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